US20050267594A1 - Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices - Google Patents

Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices Download PDF

Info

Publication number
US20050267594A1
US20050267594A1 US11184803 US18480305A US2005267594A1 US 20050267594 A1 US20050267594 A1 US 20050267594A1 US 11184803 US11184803 US 11184803 US 18480305 A US18480305 A US 18480305A US 2005267594 A1 US2005267594 A1 US 2005267594A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
uhmwpe
melting
bearing component
prosthesis
irradiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11184803
Inventor
Edward Merrill
William Harris
Murali Jasty
Charles Bragdon
Daniel O'Connor
Premnath Venugopalan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Massachusetts Institute of Technology
Original Assignee
General Hospital Corp
Massachusetts Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/46Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
    • A61F2/468Testing instruments for artificial joints
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/46Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
    • A61F2/4657Measuring instruments used for implanting artificial joints
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/16Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external and/or bone-contacting surfaces, e.g. coating for improving bone ingrowth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/34Acetabular cups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • A61F2/3662Femoral shafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006Properties of materials and coating materials
    • A61F2002/30065Properties of materials and coating materials thermoplastic, i.e. softening or fusing when heated, and hardening and becoming rigid again when cooled
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006Properties of materials and coating materials
    • A61F2002/30084Materials having a crystalline structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/3011Cross-sections or two-dimensional shapes
    • A61F2002/30112Rounded shapes, e.g. with rounded corners
    • A61F2002/30125Rounded shapes, e.g. with rounded corners elliptical or oval
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/3011Cross-sections or two-dimensional shapes
    • A61F2002/30138Convex polygonal shapes
    • A61F2002/30158Convex polygonal shapes trapezoidal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30317The prosthesis having different structural features at different locations within the same prosthesis
    • A61F2002/30324The prosthesis having different structural features at different locations within the same prosthesis differing in thickness
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30535Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30604Special structural features of bone or joint prostheses not otherwise provided for modular
    • A61F2002/30616Sets comprising a plurality of prosthetic parts of different sizes or orientations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30667Features concerning an interaction with the environment or a particular use of the prosthesis
    • A61F2002/30682Means for preventing migration of particles released by the joint, e.g. wear debris or cement particles
    • A61F2002/30685Means for reducing or preventing the generation of wear particulates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external and/or bone-contacting surfaces, e.g. coating for improving bone ingrowth
    • A61F2002/30934Special articulating surfaces
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2002/3233Joints for the hip having anti-luxation means for preventing complete dislocation of the femoral head from the acetabular cup
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/34Acetabular cups
    • A61F2002/3453Acetabular cups having a non-hemispherical convex outer surface, e.g. quadric-shaped
    • A61F2002/3462Acetabular cups having a non-hemispherical convex outer surface, e.g. quadric-shaped having a frustoconical external shape, e.g. entirely frustoconical
    • A61F2002/3464Acetabular cups having a non-hemispherical convex outer surface, e.g. quadric-shaped having a frustoconical external shape, e.g. entirely frustoconical partially frustoconical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/34Acetabular cups
    • A61F2002/348Additional features
    • A61F2002/349Shell having a wavy or undulated peripheral rim
    • A61F2002/3491Shell having a wavy or undulated peripheral rim partial, i.e. not extending along the entire equatorial circumference
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/34Acetabular cups
    • A61F2002/348Additional features
    • A61F2002/3493Spherical shell significantly greater than a hemisphere, e.g. extending over more than 200 degrees
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/34Acetabular cups
    • A61F2002/348Additional features
    • A61F2002/3495Spherical shell significantly smaller than a hemisphere, e.g. extending over less than 160 degrees
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • A61F2/3609Femoral heads or necks; Connections of endoprosthetic heads or necks to endoprosthetic femoral shafts
    • A61F2002/3611Heads or epiphyseal parts of femur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • A61F2/3609Femoral heads or necks; Connections of endoprosthetic heads or necks to endoprosthetic femoral shafts
    • A61F2002/3611Heads or epiphyseal parts of femur
    • A61F2002/3623Non-spherical heads
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • A61F2/3609Femoral heads or necks; Connections of endoprosthetic heads or necks to endoprosthetic femoral shafts
    • A61F2002/3625Necks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • A61F2/3609Femoral heads or necks; Connections of endoprosthetic heads or necks to endoprosthetic femoral shafts
    • A61F2002/3625Necks
    • A61F2002/3631Necks with an integral complete or partial peripheral collar or bearing shoulder at its base
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • A61F2/3609Femoral heads or necks; Connections of endoprosthetic heads or necks to endoprosthetic femoral shafts
    • A61F2002/365Connections of heads to necks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/46Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
    • A61F2002/4631Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor the prosthesis being specially adapted for being cemented
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/46Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
    • A61F2/4657Measuring instruments used for implanting artificial joints
    • A61F2002/4666Measuring instruments used for implanting artificial joints for measuring force, pressure or mechanical tension
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0071Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof thermoplastic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • A61F2230/0008Rounded shapes, e.g. with rounded corners elliptical or oval
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0017Angular shapes
    • A61F2230/0026Angular shapes trapezoidal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0036Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in thickness
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00011Metals or alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00011Metals or alloys
    • A61F2310/00017Iron- or Fe-based alloys, e.g. stainless steel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00011Metals or alloys
    • A61F2310/00023Titanium or titanium-based alloys, e.g. Ti-Ni alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00011Metals or alloys
    • A61F2310/00029Cobalt-based alloys, e.g. Co-Cr alloys or Vitallium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00011Metals or alloys
    • A61F2310/00035Other metals or alloys
    • A61F2310/00071Nickel or Ni-based alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00179Ceramics or ceramic-like structures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/24Materials or treatment for tissue regeneration for joint reconstruction
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE, IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C35/00Heating, cooling or curing, e.g. crosslinking or vulcanising; Apparatus therefor
    • B29C35/02Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould
    • B29C35/08Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation
    • B29C35/0805Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using electromagnetic radiation
    • B29C2035/085Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using electromagnetic radiation using gamma-ray
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE, IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C43/00Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE, IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C43/00Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
    • B29C43/02Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor of articles of definite length, i.e. discrete articles
    • B29C43/16Forging
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE, IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS
    • B29K2995/00Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
    • B29K2995/0037Other properties
    • B29K2995/0087Wear resistance
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE, IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS
    • B29K2995/00Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
    • B29K2995/0037Other properties
    • B29K2995/0089Impact strength, toughness
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE, IN GENERAL
    • B29LINDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00Other particular articles
    • B29L2031/753Medical equipment; Accessories therefor
    • B29L2031/7532Artificial members, protheses
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F110/00Homopolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond
    • C08F110/02Ethene
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/31504Composite [nonstructural laminate]
    • Y10T428/31678Of metal
    • Y10T428/31692Next to addition polymer from unsaturated monomers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/31504Composite [nonstructural laminate]
    • Y10T428/31855Of addition polymer from unsaturated monomers

Abstract

A medical prosthesis for use within the body which is formed of radiation treated ultra high molecular weight polyethylene having substantially no detectable free radicals, is described. Preferred prostheses exhibit reduced production of particles from the prosthesis during wear of the prosthesis, and are substantially oxidation resistant. Methods of manufacture of such devices and material used therein are also provided.

Description

  • This application is a continuation-in-part of application Ser. No. 08/726,313, filed on Oct. 2, 1996, entitled RADIATION AND MELT TREATED ULTRA HIGH MOLECULAR WEIGHT POLYETHYLENE PROSTHETIC DEVICES, which is a continuation-in-part of application Ser. No. 08/600,744, filed on Feb. 13, 1996, entitled MELT-IRRADIATED ULTRA HIGH MOLECULAR WEIGHT POLYETHYLENE PROSTHETIC DEVICES. The entire contents of the parent applications are expressly incorporated by reference.
  • FIELD OF THE INVENTION
  • The present invention relates to the orthopedic field and the provision of prostheses, such as hip and knee implants, as well as methods of manufacture of such devices and material used therein.
  • BACKGROUND OF THE INVENTION
  • The use of synthetic polymers, e.g., ultra high molecular weight polyethylene, with metallic alloys has revolutionized the field of prosthetic implants, e.g., their use in total joint replacements for the hip or knee. Wear of the synthetic polymer against the metal of the articulation, however, can result in severe adverse effects which predominantly manifest after several years. Various studies have concluded that such wear can lead to the liberation of ultrafine particles of polyethylene into the periprosthetic tissues. It has been suggested that the abrasion stretches the chain folded crystallites to form anisotropic fibrillar structures at the articulating surface. The stretched-out fibrils can then rupture, leading to production of submicron sized particles. In response to the progressive ingress of these polyethylene particles between the prosthesis and bone, macrophage-induced resorption of the periprosthetic bone is initiated. The macrophage, often being unable to digest these polyethylene particles, synthesize and release large numbers of cytokines and growth factors which can ultimately result in bone resorption by osteoclasts and monocytes. This osteolysis can contribute to mechanical loosening of the prosthesis components, thereby sometimes requiring revision surgery with its concomitant problems.
  • SUMMARY OF THE INVENTION
  • It is an object of the invention to provide an implantable prosthesis device formed at least in part of radiation treated ultra high molecular weight polyethylene (UHMWPE) having no detectable free radicals, so as to reduce production of fine particles from the prosthesis during wear of the prosthesis.
  • It is another object of the invention to reduce osteolysis and inflammatory reactions resulting from prosthesis implants.
  • It is yet another object of the invention to provide a prosthesis which can remain implanted within a person for prolonged periods of time.
  • It is yet another object of the invention to provide improved UHMWPE which can be used in the prostheses of the preceding objects and/or in other fabricated articles.
  • Still another object of the invention is to provide improved UHMWPE which has a high density of cross-links and no detectable free radicals.
  • A still further object of the invention is to provide improved UHMWPE which has improved wear resistance.
  • According to the invention, a medical prosthesis for use within the body which is formed of radiation treated ultra high molecular weight polyethylene (UHMWPE) having substantially no detectable free radicals, is provided. The radiation can be, e.g., gamma or electron radiation. The UHMWPE has a cross-linked structure. Preferably, the UHMWPE is substantially not oxidized and is substantially oxidation resistant. Variations include, e.g., the UHMWPE having three melting peaks, two melting peaks or one melting peak. In certain embodiments, the UHMWPE has a polymeric structure with less than about 50% crystallinity, less than about 290 Å lamellar thickness and less than about 940 MPa tensile elastic modulus, so as to reduce production of fine particles from the prosthesis during wear of the prosthesis. Part of the prosthesis can be, e.g., in the form of a cup or tray shaped article having a load bearing surface made of this UHMWPE. This load bearing surface can be in contact with a second part of the prosthesis having a mating load bearing surface of a metallic or ceramic material.
  • Another aspect of the invention is radiation treated UHMWPE having substantially no detectable free radicals. This UHMWPE has a cross-linked structure. Preferably, this UHMWPE is substantially not oxidized and is substantially oxidation resistant. Variations include, e.g., the UHMWPE having three melting peaks, two melting peaks or one melting peak.
  • Other aspects of the invention are fabricated articles, e.g., with a load bearing surface, and wear resistant coatings, made from such UHMWPE. One embodiment is where the fabricated article is in the form of a bar stock which is capable of being shaped into articles by conventional methods, e.g., machining.
  • Yet another aspect of the invention includes a method for making a cross-linked UHMWPE having substantially no detectable free radicals. Conventional UHMWPE having polymeric chains is provided. This UHMWPE is irradiated so as to cross-link said polymeric chains. The UHMWPE is heated above the melting temperature of the UHMWPE so that there are substantially no detectable free radicals in the UHMWPE. The UHMWPE is then cooled to room temperature. In certain embodiments, the cooled UHMWPE is machined and/or sterilized.
  • One preferred embodiment of this method is called CIR-SM, i.e., cold irradiation and subsequent melting. The UHMWPE that is provided is at room temperature or below room temperature.
  • Another preferred embodiment of this method is called WIR-SM, i.e., warm irradiation and subsequent melting. The UHMWPE that is provided is pre-heated to a temperature below the melting temperature of the UHMWPE.
  • Another preferred embodiment of this method is called WIR-AM, i.e., warm irradiation and adiabatic melting. In this embodiment, the UHMWPE that is provided is pre-heated to a temperature below the melting temperature of the UHMWPE, preferably between about 100° C. to below the melting temperature of the UHMWPE. Preferably, the UHMWPE is in an insulating material so as to reduce heat loss from the UHMWPE during processing. The pre-heated UHMWPE is then irradiated to a high enough total dose and at a fast enough dose rate so as to generate enough heat in the polymer to melt substantially all the crystals in the material and thus ensure elimination of substantially all detectable free radicals generated by, e.g., the irradiating step. It is preferred that the irradiating step use electron irradiation so as to generate such adiabatic heating.
  • Another aspect of this invention is the product made in accordance with the above described method.
  • Yet another aspect of this invention, called MIR, i.e., melt irradiation, is a method for making crosslinked UHMWPE. Conventional UHMWPE is provided. Preferably, the UHMWPE is surrounded with an inert material that is substantially free of oxygen. The UHMWPE is heated above the melting temperature of the UHMWPE so as to completely melt all crystalline structure. The heated UHMWPE is irradiated, and the irradiated UHMWPE is cooled to about 25° C.
  • In an embodiment of MIR, highly entangled and crosslinked UHMWPE is made. Conventional UHMWPE is provided. Preferably, the UHMWPE is surrounded with an inert material that is substantially free of oxygen. The UHMWPE is heated above the melting temperature of the UHMWPE for a time sufficient to enable the formation of entangled polymer chains in the UHMWPE. The heated UHMWPE is irradiated so as to trap the polymer chains in the entangled state, and the irradiated UHMWPE is cooled to about 25° C.
  • The invention also features a method of making a medical prosthesis from radiation treated UHMWPE having substantially no detectable free radicals, the prosthesis resulting in reduced production of particles from the prosthesis during wear of the prosthesis. Radiation treated UHMWPE having no detectable free radicals is provided. A medical prosthesis is formed from this UHMWPE so as to reduce production of particles from the prosthesis during wear of the prosthesis, the UHMWPE forming a load bearing surface of the prosthesis. Formation of the prosthesis can be accomplished by standard procedures known to those skilled in the art, e.g., machining.
  • Also provided in this invention is a method of treating a body in need of a medical prosthesis. A shaped prosthesis formed of radiation treated UHMWPE having substantially no detectable free radicals is provided. The prosthesis is applied to the body in need of the prosthesis. The prosthesis reduces production of particles from the prosthesis during wear of the prosthesis. In preferred embodiments, the UHMWPE forms a load bearing surface of the prosthesis.
  • The above and other objects, features and advantages of the present invention will be better understood from the following specification when read in conjunction with the accompanying drawings.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a cross-sectional view through the center of a medical hip joint prosthesis in accordance with a preferred embodiment of this invention;
  • FIG. 2 is a side view of an acetabular cup liner as shown in FIG. 1;
  • FIG. 3 is a cross-sectional view through line 3-3 of FIG. 2;
  • FIG. 4 is a graph showing the crystallinity and melting point of melt-irradiated UHMWPE at different irradiation doses;
  • FIG. 5 is an environmental scanning electron micrograph of an etched surface of conventional UHMWPE showing its crystalline structure;
  • FIG. 6 is an environmental scanning electron micrograph of an etched surface of melt-irradiated UHMWPE showing its crystalline structure at approximately the same magnification as in FIG. 5; and
  • FIG. 7 is a graph showing the crystallinity and melting point at different depths of a melt-irradiated UHMWPE cup.
  • FIG. 8 is a graph showing DSC melting endotherms for Hoechst-Celanese GUR 4050 UHMWPE prepared using warm irradiation and partial adiabatic melting (WIR-AM), with and without subsequent heating.
  • FIG. 9 is a graph showing DSC melting endotherms for Hoechst-Celanese GUR 1050 UHMWPE prepared using warm irradiation and partial adiabatic melting (WIR-AM), with and without subsequent heating.
  • FIG. 10 is a graph showing adiabatic heating of UHMWPE treated by WIR-AM with a pre-heat temperature of 130° C.
  • FIG. 11 is a graph showing tensile deformation behavior of unirradiated UHMWPE, CIR-SM treated UHMWPE, and WIR-AM treated UHMWPE.
  • DETAILED DESCRIPTION
  • This invention provides a medical prosthesis for use within the body which is formed of radiation treated ultra high molecular weight polyethylene (UHMWPE) which has substantially no detectable free radicals.
  • A medical prosthesis in the form of a hip joint prosthesis is generally illustrated at 10 in FIG. 1. The prosthesis shown has a conventional ball head 14 connected by a neck portion to a stem 15 which is mounted by conventional cement 17 to the femur 16. The ball head can be of conventional design and formed of stainless steel or other alloys as known in the art. The radius of the ball head closely conforms to the inner cup radius of an acetabular cup 12 which can be mounted in cement 13 directly to the pelvis 11. Alternatively, a metallic acetabular shell can be cemented to the pelvis 11 and the acetabular cup 12 can form a coating or liner connected to the metallic acetabular shell by means as are known in the art.
  • The specific form of the prosthesis can vary greatly as known in the art. Many hip joint constructions are known and other prostheses such as knee joints, shoulder joints, ankle joints, elbow joints and finger joints are known. All such prior art prostheses can be benefited by making at least one load bearing surface of such prosthesis of a high molecular weight polyethylene material in accordance with this invention. Such load bearing surfaces can be in the form of layers, linings or actual whole devices as shown in FIG. 1. In all cases, it is preferred that the load bearing surface act in conjunction with a metallic or ceramic mating member of the prosthesis so that a sliding surface is formed therebetween. Such sliding surfaces are subject to breakdown of the polyethylene as known in the prior art. Such breakdown can be greatly diminished by use of the materials of the present invention.
  • FIG. 2 shows the acetabular cup 12 in the form of a half hollow ball-shaped device better seen in the cross-section of FIG. 3. As previously described, the outer surface 20 of the acetabular cup need not be circular or hemispherical but can be square or of any configuration to be adhered directly to the pelvis or to the pelvis through a metallic shell as known in the art. The radius of the acetabular cup shown at 21 in FIG. 3 of the preferred embodiment ranges from about 20 mm to about 35 mm. The thickness of the acetabular cup from its generally hemispherical hollow portion to the outer surface 20 is preferably about 8 mm. The outer radius is preferably in the order of about 20 mm to about 35 mm.
  • In some cases, the ball joint can be made of the UHMWPE of this invention and the acetabular cup formed of metal, although it is preferred to make the acetabular cup or acetabular cup liner of UHMWPE to mate with the metallic ball. The particular method of attachment of the components of the prosthesis to the bones of the body can vary greatly as known in the art.
  • The medical prosthesis of this invention is meant to include whole prosthetic devices or portions thereof, e.g., a component, layer or lining. The medical prosthesis includes, e.g., orthopedic joint and bone replacement parts, e.g., hip, knee, shoulder, elbow, ankle or finger replacements. The prosthesis can be in the form, e.g., of a cup or tray shaped article which has a load bearing surface. Other forms known to those skilled in the art are also included in the invention. Medical prostheses are also meant to include any wearing surface of a prosthesis, e.g., a coating on a surface of a prosthesis in which the prosthesis is made from a material other than the UHMWPE of this invention.
  • The prostheses of this invention are useful for contact with metal containing parts formed of, e.g., cobalt chromium alloy, stainless steel, titanium alloy or nickel cobalt alloy, or with ceramic containing parts. For example, a hip joint is constructed in which a cup shaped article having an inner radius of 25 mm, is contacted with a metal ball having an outer radius of 25 mm, so as to closely mate with the cup shaped article. The load bearing surface of the cup shaped article of this example is made from the UHMWPE of this invention, preferably having a thickness of at least about 1 mm, more preferably having a thickness of at least about 2 mm, more preferably having a thickness of at least about ¼ inch, and more preferably yet having a thickness of at least about ⅓ inch.
  • The prostheses can have any standard known form, shape, or configuration, or be a custom design, but have at least one load bearing surface of UHMWPE of this invention.
  • The prostheses of this invention are non-toxic to humans. They are not subject to deterioration by normal body constituents, e.g., blood or interstitial fluids. They are capable of being sterilized by standard means, including, e.g., heat or ethylene oxide.
  • By UHMWPE is meant linear non-branched chains of ethylene that have molecular weights in excess of about 500,000, preferably above about 1,000,000, and more preferably above about 2,000,000. Often the molecular weights can be at least as high as about 8,000,000. By initial average molecular weight is meant the average molecular weight of the UHMWPE starting material, prior to any irradiation.
  • Conventional UHMWPE is standardly generated by Ziegler-Natta catalysis, and as the polymer chains are generated from the surface catalytic site, they crystallize, and interlock as chain folded crystals. Examples of known UHMWPE powders include Hifax Grade 1900 polyethylene (obtained from Montell, Wilmington, Del.), having a molecular weight of about 2 million g/mol and not containing any calcium stearate; GUR 4150, also known as GUR 415, (obtained from Hoescht Celanese Corp., Houston, Tex.), having a molecular weight of about 4-5 million g/mol and containing 500 ppm of calcium stearate; GUR 4050 (obtained from Hoescht Celanese Corp., Houston, Tex.), having a molecular weight of about 4-5 million g/mol and not containing any calcium stearate; GUR 4120 (obtained from Hoescht Celanese Corp., Houston, Tex.), having a molecular weight of about 2 million g/mol and containing 500 ppm of calcium stearate; GUR 4020 (obtained from Hoescht Celanese Corp., Houston, Tex.), having a molecular weight of about 2 million g/mol and not containing any calcium stearate; GUR 1050 (obtained from Hoescht Celanese Corp., Germany), having a molecular weight of about 4-5 million g/mol and not containing any calcium stearate; GUR 1150 (obtained from Hoescht Celanese Corp., Germany), having a molecular weight of about 4-5 million g/mol and containing 500 ppm of calcium stearate; GUR 1020 (obtained from Hoescht Celanese Corp., Germany), having a molecular weight of about 2 million g/mol and not containing any calcium stearate; and GUR 1120 (obtained from Hoescht Celanese Corp., Germany), having a molecular weight of about 2 million g/mol and containing 500 ppm of calcium stearate. Preferred UHMWPEs for medical applications are GUR 4150, GUR 1050 and GUR 1020. By resin is meant powder.
  • UHMWPE powder can be consolidated using a variety of different techniques, e.g., ram extrusion, compression molding or direct compression molding. In ram extrusion, the UHMWPE powder is pressurized through a heated barrel whereby it is consolidated into a rod stock, i.e., bar stock (can be obtained, e.g., from Westlake Plastics, Lenni, Pa.). In compression molding, the UHMWPE powder is consolidated under high pressure into a mold (can be obtained, e.g., from Poly-Hi Solidur, Fort Wayne, Ind., or Perplas, Stanmore, U.K.). The shape of the mold can be, e.g., a thick sheet. Direct compression molding is preferably used to manufacture net shaped products, e.g., acetabular components or tibial knee inserts (can be obtained, e.g., from Zimmer, Inc., Warsaw, Ind.). In this technique, the UHMWPE powder is compressed directly into the final shape. “Hockey pucks”, or pucks, are generally machined from ram extruded bar stock or from a compression molded sheet.
  • By radiation treated UHMWPE is meant UHMWPE which has been treated with radiation, e.g., gamma radiation or electron radiation, so as to induce cross-links between the polymeric chains of the UHMWPE.
  • By substantially no detectable free radicals is meant substantially no free radicals as measured by electron paramagnetic resonance, as described in Jahan et al., J. Biomedical Materials Research 25:1005 (1991). Free radicals include, e.g., unsaturated trans-vinylene free radicals. UHMWPE that has been irradiated below its melting point with ionizing radiation contains cross-links as well as long-lived trapped free radicals. These free radicals react with oxygen over the long-term and result in the embrittlement of the UHMWPE through oxidative degradation. An advantage of the UHMWPE and medical prostheses of this invention is that radiation treated UHMWPE is used which has no detectable free radicals. The free radicals can be eliminated by any method which gives this result, e.g., by heating the UHMWPE above its melting point such that substantially no residual crystalline structure remains. By eliminating the crystalline structure, the free radicals are able to recombine and thus are eliminated.
  • The UHMWPE which is used in this invention has a cross-linked structure. An advantage of having a cross-linked structure is that it will reduce production of particles from the prosthesis during wear of the prosthesis.
  • It is preferred that the UHMWPE be substantially not oxidized. By substantially not oxidized is meant that the ratio of the area under the carbonyl peak at 1740 cm−1 in the FTIR spectra to the area under the peak at 1460 cm−1 in the FTIR spectra of the cross-linked sample be of the same order of magnitude as the ratio for the sample before cross-linking.
  • It is preferred that the UHMWPE be substantially oxidation resistant. By substantially oxidation resistant is meant that it remains substantially not oxidized for at least about 10 years. Preferably, it remains substantially not oxidized for at least about 20 years, more preferably for at least about 30 years, more preferably yet for at least about 40 years, and most preferably for the entire lifetime of the patient.
  • In certain embodiments, the UHMWPE has three melting peaks. The first melting peak preferably is about 105° C. to about 120° C., more preferably is about 110° C. to about 120° C., and most preferably is about 118° C. The second melting peak preferably is about 125° C. to about 140° C., more preferably is about 130° C. to about 140° C., more preferably yet is about 135° C., and most preferably is about 137° C. The third melting peak preferably is about 140° C. to about 150° C., more preferably is about 140° C. to about 145° C., and most preferably is about 144° C. In certain embodiments, the UHMWPE has two melting peaks. The first melting peak preferably is about 105° C. to about 120° C., more preferably is about 110° C. to about 120° C., and most preferably is about 118° C. The second melting peak preferably is about 125° C. to about 140° C., more preferably is about 130° C. to about 140° C., more preferably yet is about 135° C., and most preferably is about 137° C. In certain embodiments, the UHMWPE has one melting peak. The melting peak preferably is about 125° C. to about 140° C., more preferably is about 130° C. to about 140° C., more preferably yet is about 135° C., and most preferably is about 137° C. Preferably, the UHMWPE has two melting peaks. The number of melting peaks is determined by differential scanning calorimetry (DSC) at a heating rate of 10° C./min.
  • The polymeric structure of the UHMWPE used in the prostheses of this invention results in the reduction of production of UHMWPE particles from the prosthesis during wear of the prosthesis. As a result of the limited number of particles being shed into the body, the prosthesis exhibits longer implant life. Preferably, the prosthesis can remain implanted in the body for at least 10 years, more preferably for at least 20 years and most preferably for the entire lifetime of the patient.
  • The invention also includes other fabricated articles made from radiation treated UHMWPE having substantially no detectable free radicals. Preferably, the UHMWPE which is used for making the fabricated articles has a cross-linked structure. Preferably, the UHMWPE is substantially oxidation resistant. In certain embodiments, the UHMWPE has three melting peaks. In certain embodiments, the UHMWPE has two melting peaks. In certain embodiments, the UHMWPE has one melting peak. Preferably, the UHMWPE has two melting peaks. The fabricated articles include shaped articles and unshaped articles, including, e.g., machined objects, e.g., cups, gears, nuts, sled runners, bolts, fasteners, cables, pipes and the like, and bar stock, films, cylindrical bars, sheeting, panels, and fibers. Shaped articles can be made, e.g., by machining. The fabricated article can be, e.g., in the form of a bar stock which is capable of being shaped into a second article by machining. The fabricated articles are particularly suitable for load bearing applications, e.g., high wear resistance applications, e.g., as a load bearing surface, e.g., an articulating surface, and as metal replacement articles. Thin films or sheets of the UHMWPE of this invention can also be attached, e.g., with glue, onto supporting surfaces, and thus used as a wear resistant load bearing surface.
  • The invention also includes radiation treated UHMWPE which has substantially no detectable free radicals. The UHMWPE has a cross-linked structure. Preferably, the UHMWPE is substantially not oxidized and is substantially oxidation resistant. In certain embodiments, the UHMWPE has three melting peaks. In certain embodiments, the UHMWPE has two melting peaks. In certain embodiments, the UHMWPE has one melting peak. Preferably, the UHMWPE has two melting peaks. Depending upon the particular processing used to make the UHMWPE, certain impurities may be present in the UHMWPE of this invention, including, e.g., calcium stearate, mold release agents, extenders, anti-oxidants and/or other conventional additives to polyethylene polymers.
  • The invention also provides a method for making cross-linked UHMWPE having substantially no detectable free radicals. Preferably, this UHMWPE is for use as a load bearing article with high wear resistance. Conventional UHMWPE having polymeric chains is provided. The conventional UHMWPE can be in the form of, e.g., a bar stock, a shaped bar stock, e.g., a puck, a coating, or a fabricated article, e.g., a cup or tray shaped article for use in a medical prosthesis. By conventional UHMWPE is meant commercially available high density (linear) polyethylene of molecular weights greater than about 500,000. Preferably, the UHMWPE starting material has an average molecular weight of greater than about 2 million. By initial average molecular weight is meant the average molecular weight of the UHMWPE starting material, prior to any irradiation. The UHMWPE is irradiated so as to cross-link the polymeric chains. The irradiation can be done in an inert or non-inert environment. Preferably, the irradiation is done in a non-inert environment, e.g., air. The irradiated UHMWPE is heated above the melting temperature of the UHMWPE so that there are substantially no detectable free radicals in the UHMWPE. The heated UHMWPE is then cooled to room temperature. Preferably, the cooling step is at a rate greater than about 0.1° C./minute. Optionally, the cooled UHMWPE can be machined. For example, if any oxidation of the UHMWPE occurred during the irradiating step, it can be machined away if desired, by any method known to those skilled in the art. And optionally, the cooled UHMWPE, or the machined UHMWPE, can be sterilized by any method known to those skilled in the art.
  • One preferred embodiment of this method is called CIR-SM, i.e., cold irradiation and subsequent melting. In this embodiment, the UHMWPE that is provided is at room temperature or below room temperature. Preferably, it is about 20° C. Irradiation of the UHMWPE can be with, e.g., gamma irradiation or electron irradiation. In general, gamma irradiation gives a high penetration depth but takes a longer time, resulting in the possibility of more in-depth oxidation. In general, electron irradiation gives more limited penetration depths but takes a shorter time, and the possibility of extensive oxidation is reduced. The irradiation is done so as to cross-link the polymeric chains. The irradiation dose can be varied to control the degree of cross-linking and crystallinity in the final UHMWPE product. Preferably, the total absorbed dose of the irradiation is about 0.5 to about 1,000 Mrad, more preferably about 1 to about 100 Mrad, more preferably yet about 4 to about 30 Mrad, more preferably yet about 20 Mrad, and most preferably about 15 Mrad. Preferably, a dose rate is used that does not generate enough heat to melt the UHMWPE. If gamma irradiation is used, the preferred dose rate is about 0.05 to about 0.2 Mrad/minute. If electron irradiation is used, preferably the dose rate is about 0.05 to about 3,000 Mrad/minute, more preferably about 0.05 to about 5 Mrad/minute, and most preferably about 0.05 to about 0.2 Mrad/minute. The dose rate in electron irradiation is determined by the following parameters: (1) the power of the accelerator in kw, (ii) the conveyor speed, (iii) the distance between the surface of the irradiated specimen and the scan horn, and (iv) the scan width. The dose rate at an e-beam facility is often measured in Mrads per pass under the rastering e-beam. The dose rates indicated herein as Mrad/minute can be converted to Mrad/pass by using the following equation:
    D Mrad/min =D Mrad/pass ×v c +l
    where DMrad/min is the dose rate in Mrad/min, DMrad/pass is the dose rate in Mrad/pass, vc is the conveyor speed and l is the length of the specimen that travels through the e-beam raster area. When electron irradiation is used, the energy of the electrons can be varied to change the depth of penetration of the electrons. Preferably, the energy of the electrons is about 0.5 MeV to about 12 MeV, more preferably about 5 MeV to about 12 MeV. Such manipulability is particularly useful when the irradiated object is an article of varying thickness or depth, e.g., an articular cup for a medical prosthesis.
  • The irradiated UHMWPE is heated above the melting temperature of the UHMWPE so that there are no detectable free radicals in the UHMWPE. The heating provides the molecules with sufficient mobility so as to eliminate the constraints derived from the crystals of the UHMWPE, thereby allowing essentially all of the residual free radicals to recombine. Preferably, the UHMWPE is heated to a temperature of about 137° C. to about 300° C., more preferably about 140° C. to about 300° C., more preferably yet about 140° C. to about 190° C., more preferably yet about 145° C. to about 300° C., more preferably yet about 145° C. to about 190° C., more preferably yet about 146° C. to about 190° C., and most preferably about 150° C. Preferably, the temperature in the heating step is maintained for about 0.5 minutes to about 24 hours, more preferably about 1 hour to about 3 hours, and most preferably about 2 hours. The heating can be carried out, e.g., in air, in an inert gas, e.g., nitrogen, argon or helium, in a sensitizing atmosphere, e.g., acetylene, or in a vacuum. It is preferred that for the longer heating times, that the heating be carried out in an inert gas or under vacuum.
  • Another preferred embodiment of this method is called WIR-SM, i.e., warm irradiation and subsequent melting. In this embodiment, the UHMWPE that is provided is pre-heated to a temperature below the melting temperature of the UHMWPE. The pre-heating can be done in an inert or non-inert environment. It is preferred that this pre-heating is done in air. Preferably, the UHMWPE is pre-heated to a temperature of about 20° C. to about 135° C., more preferably to a temperature greater than about 20° C. to about 135° C., and most preferably to a temperature of about 50° C. The other parameters are as described above for the CIR-SM embodiment, except that the dose rate for the irradiating step using electron irradiation is preferably about 0.05 to about 10 Mrad/minute, and more preferably is about 4 to about 5 Mrad/minute; and the dose rate for the irradiating step using gamma irradiation is preferably about 0.05 to about 0.2 Mrad/minute, and more preferably is about 0.2 Mrad/minute.
  • Another preferred embodiment of this method is called WIR-AM, i.e., warm irradiation and adiabatic melting. In this embodiment, the UHMWPE that is provided is pre-heated to a temperature below the melting temperature of the UHMWPE. The pre-heating can be done in an inert or non-inert environment. It is preferred that this pre-heating is done in air. The pre-heating can be done, e.g., in an oven. It is preferred that the pre-heating is to a temperature between about 100° C. to below the melting temperature of the UHMWPE. Preferably, the UHMWPE is pre-heated to a temperature of about 100° C. to about 135° C., more preferably the temperature is about 130° C., and most preferably is about 120° C. Preferably, the UHMWPE is in an insulating material so as to reduce heat loss from the UHMWPE during processing. The heat is meant to include, e.g., the pre-heat delivered before irradiation and the heat generated during irradiation. By insulating material is meant any type of material which has insulating properties, e.g., a fiberglass pouch.
  • The pre-heated UHMWPE is then irradiated to a high enough total dose and at a fast enough dose rate so as to generate enough heat in the polymer to melt substantially all the crystals in the material and thus ensure elimination of substantially all detectable free radicals generated by, e.g., the irradiating step. It is preferred that the irradiating step use electron irradiation so as to generate such adiabatic heating. By adiabatic heating is meant no loss of heat to the surroundings during irradiation. Adiabatic heating results in adiabatic melting if the temperature is above the melting point. Adiabatic melting is meant to include complete or partial melting. The minimum total dose is determined by the amount of heat necessary to heat the polymer from its initial temperature (i.e., the pre-heated temperature discussed above) to its melting temperature, and the heat necessary to melt all the crystals, and the heat necessary to heat the polymer to a pre-determined temperature above its melting point. The following equation describes how the amount of total dose is calculated:
    Total Dose=c Pa(T m −T i)+ΔH m +c Pm(T f −T m)
    where cPa (=2 J/g/° C.) and cPm (=3 J/g/° C.) are heat capacities of UHMWPE in the solid state and melt state, respectively, ΔHm (=146 J/g) is the heat of melting of the unirradiated Hoescht Celanese GUR 415 bar stock, Ti is the initial temperature, and Tf is the final temperature. The final temperature should be above the melting temperature of the UHMWPE.
  • Preferably, the final temperature of the UHMWPE is about 140° C. to about 200° C., more preferably it is about 145° C. to about 190° C., more preferably yet it is about 146° C. to about 190° C., and most preferably it is about 150° C. At above 160° C., the polymer starts to form bubbles and cracks. Preferably, the dose rate of the electron irradiation is about 2 to about 3,000 Mrad/minute, more preferably yet is about 2 to about 30 Mrad/minute, more preferably yet is about 7 to about 25 Mrad/minute, more preferably yet is about 20 Mrad/minute, and most preferably is about 7 Mrad/minute. Preferably, the total absorbed dose is about 1 to about 100 Mrad. Using the above equation, the absorbed dose for an initial temperature of 130° C. and a final temperature of 150° C. is calculated to be about 22 Mrad.
  • In this embodiment, the heating step of the method results from the adiabatic heating described above.
  • In certain embodiments, the adiabatic heating completely melts the UHMWPE. In certain embodiments, the adiabatic heating only partially melts the UHMWPE. Preferably, additional heating of the irradiated UHMWPE is done subsequent to the irradiation induced adiabatic heating so that the final temperature of the UHMWPE after the additional heating is above the melting temperature of the UHMWPE, so as to ensure complete melting of the UHMWPE. Preferably, the temperature of the UHMWPE from the additional heating is about 140° C. to about 200° C., more preferably is about 145° C. to about 190° C., more preferably yet is about 146° C. to about 190° C., and most preferably is about 150° C.
  • Yet another embodiment of this invention is called CIR-AM, i.e., cold irradiation and adiabatic heating. In this embodiment, UHMWPE at room temperature or below room temperature is melted by adiabatic heating, with or without subsequent additional heating, as described above.
  • This invention also includes the product made in accordance with the above described method.
  • Also provided in this invention is a method of making a medical prosthesis from UHMWPE having substantially no detectable free radicals, the prosthesis resulting in the reduced production of particles from the prosthesis during wear of the prosthesis. Radiation treated UHMWPE having no detectable free radicals is provided. A medical prosthesis is formed from this UHMWPE so as to reduce production of particles from the prosthesis during wear of the prosthesis, the UHMWPE forming a load bearing surface of the prosthesis. Formation of the prosthesis can be accomplished by standard procedures known to those skilled in the art, e.g., machining.
  • Also provided in this invention is a method of treating a body in need of a medical prosthesis. A shaped prosthesis formed of radiation treated UHMWPE having substantially no detectable free radicals is provided. This prosthesis is applied to the body in need of the prosthesis. The prosthesis reduces production of fine particles from the prosthesis during wear of the prosthesis. In preferred embodiments, the ultra high molecular weight polyethylene forms a load bearing surface of the prosthesis.
  • In yet another embodiment of this invention, a medical prosthesis for use within the body which is formed of ultra high molecular weight polyethylene (UHMWPE) which has a polymeric structure with less than about 50% crystallinity, less than about 290 Å lamellar thickness and less than about 940 MPa tensile elastic modulus, so as to reduce production of fine particles from the prosthesis during wear of the prosthesis, is provided.
  • The UHMWPE of this embodiment has a polymeric structure with less than about 50% crystallinity, preferably less than about 40% crystallinity. By crystallinity is meant the fraction of the polymer that is crystalline. The crystallinity is calculated by knowing the weight of the sample (w, in g), the heat absorbed by the sample in melting (E, in cal) and the calculated heat of melting of polyethylene in the 100% crystalline state (ΔH°=69.2 cal/g), and using the following equation: % crystallinity = E w · Δ H °
  • The UHMWPE of this embodiment has a polymeric structure with less than about 290 Å lamellar thickness, preferably less than about 200 Å lamellar thickness, and most preferably less than about 100 Å lamellar thickness. By lamellar thickness (l) is meant the calculated thickness of assumed lamellar structures in the polymer using the following expression: 1 = 2 · σ e · T m ° Δ H ° · ( T m ° - T m ) · ρ
    where, σe is the end free surface energy of polyethylene (2.22×10−6 cal/cm2), ΔH° is the calculated heat of melting of polyethylene in the 100% crystalline state (69.2 cal/g), ρ is the density of the crystalline regions (1.005 g/cm3), Tm° is the melting point of a perfect polyethylene crystal (418.15K) and Tm is the experimentally determined melting point of the sample.
  • The UHMWPE of this embodiment has less than about 940 MPa tensile elastic modulus, preferably less than about 600 MPa tensile elastic modulus, more preferably less than about 400 MPa tensile elastic modulus, and most preferably less than about 200 MPa tensile elastic modulus. By tensile elastic modulus is meant the ratio of the nominal stress to corresponding strain for strains less than 0.5% as determined using the standard test ASTM 638 M III.
  • Preferably, the UHMWPE of this embodiment has a polymeric structure with about 40% crystallinity, about 100 Å lamellar thickness and about 200 MPa tensile elastic modulus.
  • The UHMWPE of this embodiment has no trapped free radicals, e.g., unsaturated trans-vinylene free radicals. It is preferred that the UHMWPE of this embodiment have a hardness less than about 65 on the Shore D scale, more preferably a hardness less than about 55 on the Shore D scale, most preferably a hardness less than about 50 on the Shore D scale. By hardness is meant the instantaneous indentation hardness measured on the Shore D scale using a durometer described in ASTM D2240. It is preferred that the UHMWPE of this embodiment be substantially not oxidized. The polymeric structure has extensive cross-linking such that a substantial portion of the polymeric structure does not dissolve in Decalin. By substantial portion is meant at least 50% of the polymer sample's dry weight. By not dissolve in Decalin is meant does not dissolve in Decalin at 150° C. over a period of 24 hours. Preferably, the UHMWPE of this embodiment has a high density of entanglement so as to cause the formation of imperfect crystals and reduce crystallinity. By the density of entanglement is meant the number of points of entanglement of polymer chains in a unit volume; a higher density of entanglement being indicated by the polymer sample's inability to crystallize to the same extent as conventional UHMWPE, thus leading to a lesser degree of crystallinity.
  • The invention also includes other fabricated articles made from the UHMWPE of this embodiment having a polymeric structure with less than about 50% crystallinity, less than about 290 Å lamellar thickness and less than about 940 MPa tensile elastic modulus. Such articles include shaped articles and unshaped articles, including, e.g., machined objects, e.g., cups, gears, nuts, sled runners, bolts, fasteners, cables, pipes and the like, and bar stock, films, cylindrical bars, sheeting, panels, and fibers. Shaped articles can be made, e.g., by machining. The fabricated articles are particularly suitable for load bearing applications, e.g., as a load bearing surface, and as metal replacement articles. Thin films or sheets of UHMWPE, which have been melt-irradiated can also be attached, e.g., with glue, onto supporting surfaces, and thus used as a transparent, wear resistant load bearing surface.
  • The invention also includes an embodiment in which UHMWPE has a unique polymeric structure characterized by less than about 50% crystallinity, less than about 290 Å lamellar thickness and less than about 940 MPa tensile elastic modulus. Depending upon the particular processing used to make the UHMWPE, certain impurities may be present in the UHMWPE of this invention, including, e.g., calcium stearate, mold release agents, extenders, anti-oxidants and/or other conventional additives to polyethylene polymers. In certain embodiments, the UHMWPE has high transmissivity of light, preferably a transmission greater than about 10% of light at 517 nm through a 1 mm thick sample, more preferably a transmission greater than about 30% of light at 517 nm through a 1 mm thick sample, and most preferably a transmission greater than about 40% of light at 517 nm through a 1 mm thick sample. Such UHMWPE is particularly useful for thin films or sheets which can be attached onto supporting surfaces of various articles, the film or sheet being transparent and wear resistant.
  • In another embodiment of this invention, a method for making crosslinked UHMWPE is provided. This method is called melt irradiation (MIR). Conventional UHMWPE is provided. Preferably, the UHMWPE is surrounded with an inert material that is substantially free of oxygen. The UHMWPE is heated above the melting temperature of the UHMWPE so as to completely melt all crystalline structure. The heated UHMWPE is irradiated, and the irradiated UHMWPE is cooled to about 25° C.
  • Preferably, the UHMWPE made from this embodiment has a polymeric structure with less than about 50% crystallinity, less than about 290 Å lamellar thickness and less than about 940 MPa tensile elastic modulus. Conventional UHMWPE, e.g., a bar stock, a shaped bar stock, a coating, or a fabricated article is provided. By conventional UHMWPE is meant commercially available high density (linear) polyethylene of molecular weights greater than about 500,000. Preferably, the UHMWPE starting material has an average molecular weight of greater than about 2 million. By initial average molecular weight is meant the average molecular weight of the UHMWPE starting material, prior to any irradiation. It is preferred that this UHMWPE is surrounded with an inert material that is substantially free of oxygen, e.g., nitrogen, argon or helium. In certain embodiments, a non-inert environment can be used. The UHMWPE is heated above its melting temperature for a time sufficient to allow all the crystals to melt. Preferably, the temperature is about 145° C. to about 230° C., and more preferably, is about 175° to about 200° C. Preferably, the heating is maintained so to keep the polymer at the preferred temperature for about 5 minutes to about 3 hours, and more preferably for about 30 minutes to about 2 hours. The UHMWPE is then irradiated with gamma irradiation or electron irradiation. In general, gamma irradiation gives a high penetration depth but takes a longer time, resulting in the possibility of some oxidation. In general, electron irradiation gives more limited penetration depths but takes a shorter time, and hence the possibility of oxidation is reduced. The irradiation dose can be varied to control the degree of crosslinking and crystallinity in the final UHMWPE product. Preferably, a dose of greater than about 1 Mrad is used, more preferably a dose of greater than about 20 Mrad is used. When electron irradiation is used, the energy of the electrons can be varied to change the depth of penetration of the electrons, thereby controlling the degree of crosslinking and crystallinity in the final UHMWPE product. Preferably, the energy is about 0.5 MeV to about 12 MeV, more preferably about 1 MeV to about 10 MeV, and most preferably about 10 MeV. Such manipulability is particularly useful when the irradiated object is an article of varying thickness or depth, e.g., an articular cup for a prosthesis. The irradiated UHMWPE is then cooled to about 25° C. Preferably, the cooling rate is equal to or greater than about 0.5° C./min, more preferably equal to or greater than about 20° C./min. In certain embodiments, the cooled UHMWPE can be machined. In preferred embodiments, the cooled irradiated UHMWPE has substantially no detectable free radicals. Examples 1, 3 and 6 describe certain preferred embodiments of the method. Examples 2, 4 and 5, and FIGS. 4 through 7, illustrate certain properties of the melt-irradiated UHMWPE obtained from these preferred embodiments, as compared to conventional UHMWPE.
  • This invention also includes the product made in accordance with the above described method.
  • In an embodiment of MIR, highly entangled and crosslinked UHMWPE is made. Conventional UHMWPE is provided. Preferably, the UHMWPE is surrounded with an inert material that is substantially free of oxygen. The UHMWPE is heated above the melting temperature of the UHMWPE for a time sufficient to enable the formation of entangled polymer chains in the UHMWPE. The heated UHMWPE is irradiated so as to trap the polymer chains in the entangled state. The irradiated UHMWPE is cooled to about 25° C.
  • This invention also includes the product made in accordance with the above described method.
  • Also provided in this invention is a method of making a prosthesis from UHMWPE so as to reduce production of fine particles from the prosthesis during wear of the prosthesis. UHMWPE having a polymeric structure with less than about 50% crystallinity, less than about 290 Å lamellar thickness and less than about 940 MPa tensile elastic modulus is provided. A prosthesis is formed from this UHMWPE, the UHMWPE forming a load bearing surface of the prosthesis. Formation of the prosthesis can be accomplished by standard procedures known to those skilled in the art, e.g., machining.
  • Also provided in this invention is a method of treating a body in need of a prosthesis. A shaped prosthesis formed of ultra high molecular weight polyethylene having a polymeric structure with less than about 50% crystallinity, less than about 290 Å lamellar thickness and less than about 940 MPa tensile elastic modulus, is provided. This prosthesis is applied to the body in need of the prosthesis. The prosthesis reduces production of fine particles from the prosthesis during wear of the prosthesis. In preferred embodiments, the ultra high molecular weight polyethylene forms a load bearing surface of the prosthesis.
  • The products and processes of this invention also apply to other polymeric materials such as high-density-polyethylene, low-density-polyethylene, linear-low-density-polyethylene and polypropylene.
  • The following non-limiting examples further illustrate the present invention.
  • EXAMPLES Example 1
  • Method of Making Melt-Irradiated UHMWPE (MIR)
  • This example illustrates electron irradiation of melted UHMWPE.
  • A cuboidal specimen (puck) of size 10 mm×12 mm×60 mm, prepared from conventional ram extruded UHMWPE bar stock (Hoescht Celanese GUR 415 bar stock obtained from Westlake Plastics, Lenni, Pa.) was placed in a chamber. The atmosphere within the chamber consisted of low oxygen nitrogen gas (<0.5 ppm oxygen gas) (obtained from AIRCO, Murray Hill, N.J.). The pressure in the chamber was approximately 1 atm. The temperature of the sample and the irradiation chamber was controlled using a heater, a variac and a thermocouple readout (manual) or temperature controller (automatic). The chamber was heated with a 270 W heating mantle. The chamber was heated (controlled by the variac) at a rate such that the steady state temperature of the sample was about 175° C. The sample was held at the steady state temperature for 30 minutes before starting the irradiation.
  • Irradiation was done using a van de Graaff generator with electrons of energy 2.5 MeV and a dose rate of 1.67 MRad/min. The sample was given a dose of 20 MRad with the electron beam hitting the sample on the 60 mm×12 mm surface. The heater was switched off after irradiation, and the sample was allowed to cool within the chamber under inert atmosphere, nitrogen gas, to 25° C. at approximately 0.5° C./minute. As a control, similar specimens were prepared using unheated and unirradiated bar stock of conventional UHMWPE.
  • Example 2
  • Comparison of Properties of GUR 415 UHMWPE Bar Stock and Melt-Irradiated (MIR) GUR 415 UHMWPE Bar Stock (20 MRad)
  • This example illustrates various properties of the irradiated and unirradiated samples of UHMWPE bar stock (GUR 415) obtained from Example 1. The tested samples were as follows: the test sample was bar stock which was molten and then irradiated while molten; control was bar stock (no heating/melting, no irradiation).
  • (A) Differential Scanning Calorimetry (DSC)
  • A Perkin-Elmer DSC7 was used with an ice-water heat sink and a heating and cooling rate of 10° C./minute with a continuous nitrogen purge. The crystallinity of the samples obtained from Example 1 was calculated from the weight of the sample and the heat of melting of polyethylene crystals (69.2 cal/g). The temperature corresponding to the peak of the endotherm was taken as the melting point. The lamellar thickness was calculated by assuming a lamellar crystalline morphology, and knowing ΔH° the heat of melting of 100% crystalline polyethylene (69.2 cal/g), the melting point of a perfect crystal (418.15 K), the density of the crystalline regions (1.005 g/cm3) and the end free surface energy of polyethylene (2.22×10−6 cal/cm2). The results are shown in Table 1 and FIG. 4.
    TABLE 1
    DSC (10° C./min)
    GUR 415 GUR 415
    (unirradiated) (melt-irradiated)
    Property 0 MRad 20 MRad
    Crystallinity (%) 50.2 37.8
    Melting Point (C.) 135.8 125.5
    Lamellar thickness (Å) 290 137

    The results indicate that the melt-irradiated sample had a more entangled and less crystalline polymeric structure than the unirradiated sample, as evidenced by lower crystallinity, lower lamellar thickness and lower melting point.
  • (B) Swell Ratio
  • The samples were cut into cubes of size 2 mm×2 mm×2 mm and kept submerged in Decalin at 150° C. for a period of 24 hours. An antioxidant (1% N-phenyl-2-naphthylamine) was added to the Decalin to prevent degradation of the sample. The swell ratio and percent extract were calculated by measuring the weight of the sample before the experiment, after swelling for 24 hours and after vacuum drying the swollen sample. The results are shown in Table 2.
    TABLE 2
    Swelling in Decalin with Antioxidant
    for 24 hours at 150° C.
    GUR 415 GUR 415
    (unirradiated) (melt-irradiated)
    Property 0 MRad 20 MRad
    Swell Ratio dissolves 2.5
    Extract (%) approx. 100% 0.0

    The results indicate that the melt-irradiated UHMWPE sample was highly crosslinked, and hence did not allow dissolution of polymer chains into the hot solvent even after 24 hours, while the unirradiated sample dissolved completely in the hot solvent in the same period.
  • (C) Tensile Elastic Modulus
  • ASTM 638 M III of the samples was followed. The displacement rate was 1 mm/minute. The experiment was performed on a MTS machine. The results are shown in Table 3.
    TABLE 3
    Elastic Test (ASTM 638 M III, 1 mm/min.
    GUR 415 GUR 415
    (unirradiated) (melt-irradiated)
    Property 0 MRad 20 MRad
    Tensile Elastic modulus (MPa) 940.7 200.8
    Yield stress 22.7 14.4
    Strain at break (%) 953.8 547.2
    Engineering UTS (MPa) 46.4 15.4

    The results indicate that the melt-irradiated UHMWPE sample had a significantly lower tensile elastic modulus than the unirradiated control. The lower strain at break of the melt-irradiated UHMWPE sample is yet further evidence for the crosslinking of chains in that sample.
  • (D) Hardness
  • The hardness of the samples was measured using a durometer on the shore D scale. The hardness was recorded for instantaneous indentation. The results are shown in Table 4.
    TABLE 4
    Hardness (Shore D)
    GUR 415 GUR 415
    (unirradiated) (melt-irradiated)
    Property 0 MRad 20 MRad
    Hardness (D Scale) 65.5 54.5

    The results indicate that the melt-irradiated UHMWPE was softer than the unirradiated control.
  • (E) Light Transmissivity (Transparency)
  • Transparency of the samples was measured as follows: Light transmission was studied for a light of wave length 517 nm passing through a sample of approximately 1 mm in thickness placed between two glass slides. The samples were prepared by polishing the surfaces against 600 grit paper. Silicone oil was spread on the surfaces of the sample and then the sample was placed in between two slides. The silicone oil was used in order to reduce diffuse light scattering due to the surface roughness of the polymer sample. The reference used for this purpose was two similar glass slides separated by a thin film of silicone oil. The transmissivity was measured using a Perkin Elmer Lambda 3B uv-vis spectrophotometer. The absorption coefficient and transmissivity of a sample exactly 1 mm thick were calculated using the Lambert-Beer law. The results are shown in Table 5.
    TABLE 5
    Transmissivity of Light at 517 nm
    GUR 415 GUR 415
    (unirradiated) (melt-irradiated)
    Property 0 MRad 20 MRad
    Transmission (%) 8.59 39.9
    (1 mm sample)
    Absorption coefficient 24.54 9.18
    (cm1)

    The results indicate that the melt-irradiated UHMWPE sample transmitted much more light through it than the control, and hence is much more transparent than the control.
  • (F) Environmental Scanning Electron Microscopy (ESEM)
  • ESEM (ElectroScan, Model 3) was performed on the samples at 10 kV (low voltage to reduce radiation damage to the sample) with an extremely thin gold coating (approximately 20 Å to enhance picture quality). By studying the surface of the polymer under the ESEM with and without the gold coating, it was verified that the thin gold coating did not produce any artifacts.
  • The samples were etched using a permanganate etch with a 1:1 sulfuric acid to orthophosphoric acid ratio and a 0.7% (w/v) concentration of potassium permanganate before being viewed under the ESEM.
  • FIG. 4 shows an ESEM (magnification of 10,000×) of an etched surface of conventional UHMWPE (GUR 415; unheated; unirradiated). FIG. 5 shows an ESEM (magnification of 10,500×) of an etched surface of melt-irradiated UHMWPE (GUR 415; melted; 20 MRad). The ESEMs indicated a reduction in size of the crystallites and the occurrence of imperfect crystallization in the melt-irradiated UHMWPE as compared to the conventional UHMWPE.
  • (G) Fourier Transform Infra Red Spectroscopy (FTIR)
  • FTIR of the samples was performed using a microsampler on the samples rinsed with hexane to remove surface impurities. The peaks observed around 1740 to 1700 cm−1 are bands associated with oxygen containing groups. Hence, the ratio of the area under the carbonyl peak at 1740 cm−1 to the area under the methylene peak at 1460 cm−1 is a measure of the degree of oxidation.
  • The FTIR spectra indicate that the melt-irradiated UHMWPE sample showed more oxidation than the conventional unirradiated UHMWPE control, but a lot less oxidation than an UHMWPE sample irradiated in air at room temperature and given the same irradiation dose as the melt-irradiated sample.
  • (H) Electron Paramagnetic Resonance (EPR)
  • EPR was performed at room temperature on the samples which were placed in a nitrogen atmosphere in an air tight quartz tube. The instrument used. was the Bruker ESP 300 EPR spectrometer and the tubes used were Taperlok EPR sample tubes obtained from Wilmad Glass Company, Buena, N.J.
  • The unirradiated samples do not have any free radicals in them since irradiation is the process which creates free radicals in the polymer. On irradiation, free radicals are created which can last for several years under the appropriate conditions.
  • The EPR results indicate that the melt-irradiated sample did not show any free radicals when studied using an EPR immediately after irradiation, whereas the sample which was irradiated at room temperature under nitrogen atmosphere showed trans-vinylene free radicals even after 266 days of storage at room temperature. The absence of free radicals in the melt-irradiated UHMWPE sample means that any further oxidative degradation was not possible.
  • (I) Wear
  • The wear resistance of the samples was measured using a bi-axial pin-on-disk wear tester. The wear test involved the rubbing action of UHMWPE pins (diameter=9 mm; height=13 mm) against a Co—Cr alloy disk. These tests were carried out to a total of 2 million cycles. The unirradiated pin displayed a wear rate of 8 mg/million-cycles while the irradiated pin had a wear rate of 0.5 mg/million cycles. The results indicate that the melt-irradiated UHMWPE has far superior wear resistance than the unirradiated control.
  • Example 3
  • Method of Making Melt-Irradiated (MIR) UHMWPE Conventional Articular Cups
  • This example illustrates electron irradiation of a melted UHMWPE conventional articular cup.
  • A conventional articular cup (high conformity unsterilized UHMWPE cup made by Zimmer, Inc., Warsaw, Ind.) of internal diameter 26 mm and made of GUR 415 ram extruded bar stock, was irradiated under controlled atmosphere and temperature conditions in an air-tight chamber with a titanium cup holder at the base and a thin stainless steel foil (0.001 inches thick) at the top. The atmosphere within this chamber consisted of low oxygen nitrogen gas (<0.5 ppm oxygen gas) (obtained from AIRCO, Murray Hill, N.H.). The pressure in the chamber was approximately 1 atm. The chamber was heated using a 270 W heating mantle at the base of the chamber which was controlled using a temperature controller and a variac. The chamber was heated such that the temperature at the top surface of the cup rose at approximately 1.5° to 2° C./min, finally asymptotically reaching a steady state temperature of approximately 175° C. Due to the thickness of the sample cup and the particular design of the equipment used, the steady state temperature of the cup varied between 200° C. at the base to 175° C. at the top. The cup was held at these temperatures for a period of 30 minutes before starting the irradiation.
  • Irradiation was done using a van de Graaff generator with electrons of energy 2.5 MeV and a dose rate of 1.67 MRad/min. The beam entered the chamber through the thin foil at top and hit the concave surface of the cup. The dose received by the cup was such that a maximum dose of 20 MRad was received approximately 5 mm below the surface of the cup being hit by the electrons. After irradiation, the heating was stopped and the cup was allowed to cool to room temperature (approximately 25° C.) while still in the chamber with nitrogen gas. The rate of cooling was approximately 0.5° C./min. The sample was removed from the chamber after the chamber and the sample had reached room temperature.
  • The above irradiated cup which increases in volume (due to the decrease in density accompanying the reduction of crystallinity following melt-irradiation) can be remachined to the appropriate dimensions.
  • Example 4
  • Swell Ratio and Percent Extract at Different Depths for Melt-Irradiated (MIR) UHMWPE Articular Cups
  • This example illustrates the swell ratio and percent extract at different depths of the melt-irradiated articular cup obtained from Example 3. Samples of size 2 mm×2 mm×2 mm were cut from the cup at various depths along the axis of the cup. These samples were then kept submerged in Decalin at 150° C. for a period of 24 hours. An antioxidant (1% N-phenyl-2-naphthylamine) was added to the Decalin to prevent degradation of the sample. The swell ratio and percent extract were calculated by measuring the weight of the sample before the experiment, after swelling for 24 hours, and after vacuum drying the swollen sample. The results are shown in Table 6.
    TABLE 6
    The Swell Ratio and Percent Extract at Different
    Depths on the Melt-Irradiated UHMWPE Articular Cup
    Swell Ratio
    Depth (mm) (Decalin, 150° C., 1 day) % Extract
    0-2 2.43 0.0
    2-4 2.52 0.0
    4-6 2.51 0.0
    6-8 2.64 0.0
     8-10 2.49 0.0
    10-12 3.68 0.0
    >12 6.19 35.8
    Unirradiated Dissolves Approx. 100%

    The results indicate that the UHMWPE in the cup had been crosslinked to a depth of 12 mm due to the melt-irradiation process to such an extent that no polymer chains dissolved out in hot Decalin over 24 hours.
  • Example 5
  • Crystallinity and Melting Point at Different Depths for the Melt-Irradiated (MIR) UHMWPE Articular Cups
  • This example illustrates the crystallinity and melting point at different depths of the melt-irradiated cup obtained from Example 3.
  • Samples were taken from the cup at various depths along the axis of the cup. The crystallinity is the fraction of the polymer that is crystalline. The crystallinity was calculated by knowing the weight of the sample (w, in g), the heat absorbed by the sample in melting (E, in cal which was measured experimentally using a Differential Scanning Calorimeter at 10° C./min) and the heat of melting of polyethylene in the 100% crystalline state (ΔH°=69.2 cal/g), using the following equation: % crystallinity = E w · Δ H °
    The melting point is the temperature corresponding to the peak in the DSC endotherm. The results are shown in FIG. 7.
  • The results indicate that the crystallinity and the melting point of the melt-irradiated UHMWPE in the articular cups obtained from Example 3 were much lower than the corresponding values of the conventional UHMWPE, even to a depth of 1 cm (the thickness of the cup being 1.2 cms).
  • Example 6
  • Second Method of Making Melt-Irradiated (MIR) UHMWPE Articular Cups
  • This example illustrates a method for making articular cups with melt-irradiated UHMWPE.
  • Conventional ram extruded UHMWPE bar stock (GUR 415 bar stock obtained from West Lake Plastics, Lenni, Pa.) was machined to the shape of a cylinder, of height 4 cm and diameter 5.2 cm. One circular face of the cylinder was machined to include an exact hemispherical hole, of diameter 2.6 cm, such that the axis of the hole and the cylinder coincided. This specimen was enclosed in an air-tight chamber with a thin stainless steel foil (0.001 inches thick) at the top. The cylindrical specimen was placed such that the hemispherical hole faced the foil. The chamber was then flushed and filled with an atmosphere of low oxygen nitrogen gas (<0.5 ppm oxygen gas) obtained from AIRCO, Murray Hill, N.J.). Following this flushing and filling, a slow continuous flow of nitrogen was maintained while keeping the pressure in the chamber at approximately 1 atm. The chamber was heated using a 270 W heating mantle at the base of the chamber which was controlled using a temperature controller and a variac. The chamber was heated such that the temperature at the top surface of the cylindrical specimen rose at approximately 1.5° C. to 2° C./min, finally asymptotically reaching a steady state temperature of approximately 175° C. The specimen was then held at this temperature for a period of 30 minutes before starting irradiation.
  • Irradiation was done using a van de Graaff generator with electrons of energy 2.5 MeV and a dose rate of 1.67 MRad/min. The beam entered the chamber through the thin foil at top and hit the surface with the hemispherical hole. The dose received by the specimen was such that a maximum dose of 20 MRad was received approximately 5 mm below the surface of the polymer being hit by the electrons. After irradiation, the heating was stopped and the specimen was allowed to cool to room temperature (approximately 25° C.) while still in the chamber with nitrogen gas. The rate of cooling was approximately 0.50° C./min. The sample was removed from the chamber after the chamber and the sample had reached room temperature.
  • This cylindrical specimen was then machined into an articular cup with the dimensions of a high conformity UHMWPE articular cup of internal diameter 26 mm manufactured by Zimmer, Inc., Warsaw, Ind., such that the concave surface of the hemispherical hole was remachined into the articulating surface. This method allows for the possibility of relatively large changes in dimensions during melt irradiation.
  • Example 7
  • Electron Irradiation of UHMWPE Pucks
  • This example illustrates that electron irradiation of UHMWPE pucks gives a non-uniform absorbed dose profile.
  • Conventional UHMWPE ram extruded bar stock (Hoescht Celanese GUR 415 bar stock obtained from Westlake Plastics, Lenni, Pa.) was used. The GUR 415 resin used for the bar stock had a molecular weight of 5,000,000 g/mol and contained 500 ppm of calcium stearate. The bar stock was cut into “hockey puck” shaped cylinders (height 4 cm, diameter 8.5 cm).
  • The pucks were irradiated at room temperature with an electron-beam incident to one of the circular bases of the pucks with a linear electron accelerator operated at 10 MeV and 1 kW (AECL, Pinawa, Manitoba, Canada), with a scan width of 30 cm and a conveyor speed of 0.08 cm/sec. Due to a cascade effect, electron beam irradiation results in a non-uniform absorbed dose profile. Table 7 illustrates the calculated absorbed dose values at various depths in a specimen of polyethylene irradiated with 10 MeV electrons. The absorbed doses were the values measured at the top surface (surface of e-beam incidence).
    TABLE 7
    The variation of absorbed dose as a function of depth
    in polyethylene
    Depth (mm) Absorbed Dose (Mrad)
    0 20
    0.5 22
    1.0 23
    1.5 24
    2.0 25
    2.5 27
    3.0 26
    3.5 23
    4.0 20
    4.5 8
    5.0 3
    5.5 1
    6.0 0
  • Example 8
  • Method of Making UHMWPE Using Cold Irradiation and Subsequent Melting (CIR-SM)
  • This example illustrates a method of making UHMWPE that has a cross-linked structure and has substantially no detectable free radicals, by cold irradiating and then melting the UHMWPE.
  • Conventional UHMWPE ram extruded bar stock (Hoescht Celanese GUR 415 bar stock obtained from Westlake Plastics, Lenni, Pa.) was used. The GUR 415 resin used for the bar stock had a molecular weight of 5,000,000 g/mol and contained 500 ppm of calcium stearate. The bar stock was cut into “hockey puck” shaped cylinders (height 4 cm, diameter 8.5 cm).
  • The pucks were irradiated at room temperature at a dose rate of 2.5 Mrad per pass to 2.5, 5, 7.5, 10, 12.5, 15, 17.5, 20, 30, and 50 Mrad total absorbed dose as measured on the top surface (electron-beam incidence) (AECL, Pinawa, Manitoba, Canada). The pucks were not packaged and the irradiation was carried out in air. Subsequent to irradiation, the pucks were heated to 150° C. under vacuum for 2 hours so as to melt the polymer and thereby result in the recombination of free radicals leading to substantially no detectable residual free radicals. The pucks were then cooled to room temperature at a rate of 5° C./min.
  • The residual free radicals are measured by electron paramagnetic resonance as described in Jahan et al., J. Biomedical Materials Research 25:1005 (1991).
  • Example 9
  • Method of Making UHMWPE Using Warm Irradiation and Subsequent Melting (WIR-SM)
  • This example illustrates a method of making UHMWPE that has a cross-linked structure and has substantially no detectable free radicals, by irradiating UHMWPE that has been heated to below the melting point, and then melting the UHMWPE.
  • Conventional UHMWPE ram extruded bar stock (Hoescht Celanese GUR 415 bar stock obtained from Westlake Plastics, Lenni, Pa.) was used. The GUR 415 resin used for the bar stock had a molecular weight of 5,000,000 g/mol and contained 500 ppm of calcium stearate. The bar stock was cut into “hockey puck” shaped cylinders (height 4 cm, diameter 8.5 cm).
  • The pucks were heated to 100° C. in air in an oven. The heated pucks were then irradiated with an electron beam to a total dose of 20 Mrad at a dose rate of 2.5 Mrad per pass (E-Beam Services, Cranbury, N.J.), with a scan width of 30 cm and a conveyor speed of 0.08 cm/sec. Subsequent to irradiation, the pucks were heated to 150° C. under vacuum for 2 hours, thereby allowing the free radicals to recombine leading to substantially no detectable residual free radicals. The pucks were then cooled to room temperature at a rate of 5° C./min.
  • Example 10
  • Method of Making UHMWPE Using warm Irradiation and Adiabatic Melting (WIR-AM)
  • This example illustrates a method of making UHMWPE that has a cross-linked structure and has substantially no detectable free radicals, by irradiating UHMWPE that has been heated to below the melting point so as to generate adiabatic melting of the UHMWPE.
  • Conventional UHMWPE ram extruded bar stock (Hoescht Celanese GUR 415 bar stock obtained from Westlake Plastics, Lenni, Pa.) was used. The GUR 415 resin used for the bar stock had a molecular weight of 5,000,000 g/mol and contained 500 ppm of calcium stearate. The bar stock was cut into “hockey puck” shaped cylinders (height 4 cm, diameter 8.5 cm).
  • Two pucks were packed in a fiberglass pouch (obtained from Fisher Scientific Co., Pittsburgh, Pa.) to minimize heat loss in subsequent processing steps. First, the wrapped pucks were heated overnight in an air convection oven kept at 120° C. As soon as the pucks were removed from the oven they were placed under an electron-beam incident to one of the circular bases of the pucks from a linear electron accelerator operated at 10 MeV and 1 kW (AECL, Pinawa, Manitoba, Canada), and immediately irradiated to a total dose of 21 and 22.5 Mrad, respectively. The dose rate was 2.7 Mrad/min. Therefore, for 21 Mrad, radiation was for 7.8 min., and for 22.5 Mrad, radiation was for 8.3 min. Following the irradiation, the pucks were cooled to room temperature at a rate of 5° C./minute, at which point the fiberglass pouch was removed and the specimens analyzed.
  • Example 11
  • Comparison of Properties of GUR 415 UHMWPE Bar Stock Pucks and CIR-SM and WIR-AM-Treated Bar Stock Pucks
  • This example illustrates various properties of the irradiated and unirradiated samples of UHMWPE bar stock GUR 415 obtained from Examples 8 and 10. The tested samples were as follows: (i) test samples (pucks) from bar stock which was irradiated at room temperature, subsequently heated to about 150° C. for complete melting of polyethylene crystals, followed by cooling to room temperature (CIR-SM), (ii) test samples (pucks) from bar stock which was heated to 120° C. in a fiberglass pouch so as to minimize heat loss from the pucks, followed by immediate irradiation to generate adiabatic melting of the polyethylene crystals (WIR-AM), and (iii) control bar stock (no heating/melting, no irradiation).
  • A. Fourier Transform Infra-Red Spectroscopy (FTIR)
  • Infra-red (IR) spectroscopy of the samples was performed using a BioRad UMA 500 infrared microscope on thin sections of the samples obtained from Examples 8 and 10. The thin sections (50 μm) were prepared with a sledge microtome. The IR spectra were collected at 20 μm, 100 μm, and 3 mm below the irradiated surface of the pucks with an aperture size of 10×50 μm2. The peaks observed around 1740 to 1700 cm−1 are associated with the oxygen containing groups. Hence, the ratio of the area under the carbonyl peak at 1740 cm−1 to the area under the methylene peak at 1460 cm−1, after subtracting the corresponding baselines, was a measure of the degree of oxidation. Tables 8 and 9 summarize the degree of oxidation for the specimens described in Examples 8 and 10.
  • These data show that following the cross-linking procedures there was some oxidation within a thin layer of about 100 μm thickness. Upon machining this layer away, the final product would have the same oxidation levels as the unirradiated control.
    TABLE 8
    Degree of oxidation of specimens from Example 8
    (CIR-SM) (with post-irradiation melting in vacuum)
    Oxidation Degree at various
    depths (A.U.)
    Specimen 20 μm 100 μm 3 mm
    Unirradiated Control 0.01 0.01 0.02
    Irradiated to 2.5 Mrad 0.04 0.03 0.03
    Irradiated to 5 Mrad 0.04 0.03 0.01
    Irradiated to 7.5 Mrad 0.05 0.02 0.02
    Irradiated to 10 Mrad 0.02 0.03 0.01
    Irradiated to 12.5 Mrad 0.04 0.03 0.01
    Irradiated to 15 Mrad 0.03 0.01 0.02
    Irradiated to 17.5 Mrad 0.07 0.05 0.02
    Irradiated to 20 Mrad 0.03 0.02 0.01
  • TABLE 9
    Degree of oxidation of specimens from Example 10
    (WIR-AM)
    Oxidation Degree at (A.U.)
    Specimen 20 μm 100 μm 3 mm
    Unirradiated Control 0.01 0.01 0.02
    Irradiated to 21 Mrad 0.02 0.01 0.03
    Irradiated to 22.5 Mrad 0.02 0.02 0.01
  • B. Differential Scanning Calorimetry (DSC)
  • A Perkin-Elmer DSC7 was used with an ice-water heat sink and a heating and cooling rate of 10° C./minute with a continuous nitrogen purge. The crystallinity of the specimens obtained from Examples 8 and 10 was calculated from the weight of the sample and the heat of melting of polyethylene crystals measured during the first heating cycle. The percent crystallinity is given by the following equation: % crystallinity = E w · Δ H °
  • where E and w are the heat of melting (J or cal) and weight (grams) of the specimen tested, respectively, and ΔH° is the heat of melting of 100% crystalline polyethylene in Joules/gram (291 J/g or 69.2 cal/g). The temperature corresponding to the peak of the endotherm was taken as the melting point. In some cases where there were multiple endotherm peaks, multiple melting points corresponding to these endotherm peaks have been reported. The crystallinities and melting points for the specimens described in Examples 8 and 10 are reported in Tables 10 and 11.
    TABLE 10
    DSC at a heating rate of 10° C./min for specimens of
    Example 8 (CIR-SM)
    Specimen Crystallinity(%) Melting Point(° C.)
    Unirradiated Control 59 137
    Irradiated to 2.5 Mrad 54 137
    Irradiated to 5 Mrad 53 137
    Irradiated to 10 Mrad 54 137
    Irradiated to 20 Mrad 51 137
    Irradiated to 30 Mrad 37 137
  • TABLE 11
    DSC at a heating rate of 10° C./min for specimens of
    Example 10 (WIR-AM)
    Specimen Crystallinity(%) Melting Point(° C.)
    Unirradiated Control 59 137
    Irradiated to 21 Mrad 54 120-135-145
    Irradiated to 22.5 Mrad 48 120-135-145
  • The data shows that the crystallinity does not change significantly up to absorbed doses of 20 Mrad. Therefore, the elastic properties of the cross-linked material should remain substantially unchanged upon cross-linking. On the other hand, one could tailor the elastic properties by changing the crystallinity with higher doses. The data also shows that the WIR-AM material exhibited three melting peaks.
  • C. Pin-on-Disc Experiments for Wear Rate
  • The pin-on-disc (POD) experiments were carried out on a bi-axial pin-on-disc tester at a frequency of 2 Hz where polymeric pins were tested by a rubbing action of the pin against a highly polished Co—Cr disc. Prior to preparing cylindrical shaped pins (height 13 mm, diameter 9 mm), one millimeter from the surface of the pucks was machined away in order to remove the outer layer that had been oxidized during irradiation and post- and pre-processing. The pins were then machined from the core of the pucks and tested on the POD such that the surface of e-beam incidence was facing the Co—Cr disc. The wear tests were carried out to a total of 2,000,000 cycles in bovine serum. The pins were weighed at every 500,000 cycle and the average values of weight loss (wear rate) are reported in Tables 12 and 13 for specimens obtained from Examples 8 and 10 respectively.
    TABLE 12
    POD wear rates for specimens of Example 8 (CIR-SM)
    Specimen Wear Rate (mg/million cycle)
    Unirradiated Control 9.78
    Irradiated to 2.5 Mrad 9.07
    Irradiated to 5 Mrad 4.80
    Irradiated to 7.5 Mrad 2.53
    Irradiated to 10 Mrad 1.54
    Irradiated to 15 Mrad 0.51
    Irradiated to 20 Mrad 0.05
    Irradiated to 30 Mrad 0.11
  • TABLE 13
    POD wear rates for specimens of Example 10
    (WIR-AM)
    Specimen Wear Rate (mg/million cycle)
    Unirradiated Control 9.78
    Irradiated to 21 Mrad 1.15
  • The results indicate that the cross-linked UHMWPE has far superior wear resistance than the unirradiated control.
  • D. Gel Content and Swell Ratio
  • The samples were cut in cubes of size 2×2×2 mm3 and kept submerged in xylene at 130° C. for a period of 24 hours. An antioxidant (1% N-phenyl-2-naphthylamine) was added to the xylene to prevent degradation of the sample. The swell ratio and gel content were calculated by measuring the weight of the sample before the experiment, after swelling for 24 hours and after vacuum drying the swollen sample. The results are shown in Tables 14 and 15 for the specimens obtained from Examples 8 and 10.
    TABLE 14
    Gel content and swell ratio for specimens of
    Example 8 (CIR-SM)
    Specimen Gel Content(%) Swell Ratio
    Unirradiated Control 89.7 12.25
    Irradiated to 5 Mrad 99.2 4.64
    Irradiated to 10 Mrad 99.9 2.48
    Irradiated to 20 Mrad 99.0 2.12
    Irradiated to 30 Mrad 99.9 2.06
  • TABLE 15
    Gel content and swell ratio for specimens of
    Example 10 (WIR-AM)
    Specimen Gel Content(%) Swell Ratio
    Unirradiated Control 89.7 12.25
    Irradiated to 21 Mrad 99.9 2.84
    Irradiated to 22.5 Mrad 100 2.36
  • The results show that the swell ratio decreased with increasing absorbed dose indicating an increase in the cross-link density. The gel content increased indicating the formation of a cross-linked structure.
  • Example 12
  • Free Radical Concentration for UHMWPE Prepared by Cold Irradiation With and Without Subsequent Melting (CIR-SM)
  • This example illustrates the effect of melting subsequent to cold irradiation of UHMWPE on the free radical concentration. Electron paramagnetic resonance (EPR) was performed at room temperature on the samples after placing in a nitrogen atmosphere in an air tight quartz tube. The instrument used was the Bruker ESP 300 EPR spectrometer and the tubes used were Taperlok EPR sample tubes (obtained from Wilmad Glass Co., Buena, N.J.).
  • The unirradiated samples did not have any detectable free radicals in them. During the process of irradiation, free radicals are created which can last for at least several years under the appropriate conditions.
  • The cold-irradiated UHMWPE specimens exhibited a strong free radical signal when tested with the EPR technique. When the same samples were examined with EPR following a melting cycle, the EPR signal was found to be reduced to undetectable levels. The absence of free radicals in the cold irradiated subsequently melted (recrystallized) UHMWPE sample means that any further oxidative degradation cannot occur via attack on entrapped radicals.
  • Example 13
  • Crystallinity and Melting Point at Different Depths for UHMWPE Prepared by Cold Irradiation and Subsequent Melting (CIR-SM)
  • This example illustrates the crystallinity and melting point at different depths of the cross-linked UHMWPE specimens obtained from Example 8 with 20 Mrad total radiation dose. Samples were taken at various depths from the cross-linked specimen. The crystallinity and the melting point were determined using a Perkin Elmer differential scanning calorimeter as described in Example 10(B). The results are shown in Table 16.
    TABLE 16
    DSC at a heating rate of 10° C./min for specimen of
    Example 8 irradiated to a total dose of 20 Mrad
    (CIR-SM)
    Depth (mm) Crystallinity(%) Melting Point(° C.)
    0-2 53 137
    6-8 54 137
     9-11 54 137
    14-16 34 137
    20-22 52 137
    26-28 56 137
    29-31 52 137
    37-40 54 137
    Unirradiated Control 59 137
  • The results indicate that the crystallinity varied as a function of depth away from the surface. The sudden drop in 16 mm is the consequence of the cascade effect. The peak in the absorbed dose was located around 16 mm where the dose level could be as high as 27 Mrad.
  • Example 14
  • Comparison of UHMWPE Prepared by CIR-SM Using Melting in Air Versus Melting Under Vacuum
  • This example illustrates that the oxidation levels of UHMWPE pucks prepared by CIR-SM, whether melted in air or under vacuum, are the same as unirradiated pucks at a depth of 3 mm below the surface of the pucks.
  • Conventional UHMWPE ram extruded bar stock (Hoescht Celanese GUR 415 bar stock obtained from Westlake Plastics, Lenni, Pa.) was used. The GUR 415 resin used for the bar stock had a molecular weight of 5,000,000 g/mol and contained 500 ppm of calcium stearate. The bar stock was cut into “hockey puck” shaped cylinders (height 4 cm, diameter 8.5 cm).
  • Two pucks were irradiated at room temperature with a dose rate of 2.5 Mrad per pass to 17.5 Mrad total absorbed dose as measured on the top surface (e-beam incidence) (AECL, Pinawa, Manitoba, Canada), with a scan width of 30 cm and a conveyor speed of 0.07 cm/sec. The pucks were not packaged and the irradiation was carried out in air. Subsequent to irradiation, one puck was heated under vacuum to 150° C. for 2 hours, and the other puck was heated in air to 150° C. for 2 hours, so as to attain a state of no detectable residual crystalline content and no detectable residual free radicals. The pucks were then cooled to room temperature at a rate of 5° C./min. The pucks were then analyzed for the degree of oxidation as described in Example 11(A). Table 17 summarizes the results obtained for the degree of oxidation.
    TABLE 17
    Degree of oxidation of specimens melted in air
    versus in vacuum
    Oxidation Degree at
    Post-Melting various depths (A.U.)
    Specimen Environment 20 μm 100 μm 3 mm
    Unirradiated Control N/A 0.01 0.01 0.02
    Irradiated to 17.5 Mrad Vacuum 0.07 0.05 0.02
    Irradiated to 17.5 Mrad Air 0.15 0.10 0.01
  • The results indicated that within 3 mm below the free surfaces the oxidation level in the irradiated UHMWPE specimens dropped to oxidation levels observed in unirradiated control UHMWPE. This was the case independent of post-irradiation melting atmosphere (air or vacuum). Therefore, post-irradiation melting could be done in an air convection oven without oxidizing the core of the irradiated puck.
  • Example 15
  • Method of Making UHMWPE Using Cold Irradiation and Subsequent Melting Using Gamma Irradiation (CIR-SM)
  • This example, illustrates a method of making UHMWPE that has a cross-linked structure and has substantially no detectable free radicals, by cold irradiating with gamma-radiation and then melting the UHMWPE.
  • Conventional UHMWPE ram extruded bar stock (Hoescht Celanese GUR 415 bar stock obtained from Westlake Plastics, Lenni, Pa.) was used. The GUR 415 resin used for the bar stock had a molecular weight of 5,000,000 g/mol and contained 500 ppm of calcium stearate. The bar stock was cut into “hockey puck” shaped cylinders (height 4 cm, diameter 8.5 cm).
  • The pucks were irradiated at room temperature at a dose rate of 0.05 Mrad/minute to 4 Mrad total absorbed dose as measured on the top surface (gamma ray incidence) (Isomedix, Northboro, Mass.). The pucks were not packaged and irradiation was carried out in air. Subsequent to irradiation, the pucks were heated to 150° C. under vacuum for 2 hours so as to melt the polymer and thereby result in the recombination of free radicals leading to substantially no detectable residual free radicals.
  • Example 16
  • I. Method of Making UHMWPE Using Warm Irradiation and Partial Adiabatic Melting with Subsequent Complete Melting (WIR-AM)
  • This example illustrates a method of making UHMWPE that has a cross-linked structure, exhibits two distinct melting endotherms in a differential scanning calorimeter (DSC), and has substantially no detectable free radicals, by irradiating UHMWPE that has been heated to below the melting point so as to generate adiabatic partial melting of the UHMWPE and by subsequently melting the UHMWPE.
  • A GUR 4050 bar stock (made from ram extruded Hoescht Celanese GUR 4050 resin obtained from Westlake Plastics, Lenni, Pa.) was machined into 8.5 cm diameter and 4 cm thick hockey pucks. Twenty-five pucks, 25 aluminum holders and 25 20 cm×20 cm fiberglass blankets were preheated to 125° C. overnight in an air convection oven. The preheated pucks were each placed in a preheated aluminum holder which was covered by a preheated fiberglass blanket to minimize heat loss to the surroundings during irradiation. The pucks were then irradiated in air using a 10 MeV, 1 kW electron beam with a scan width of 30 cm (AECL, Pinawa, Manitoba, Canada). The conveyor speed was 0.07 cm/sec which gave a dose rate of 70 kGy per pass. The pucks were irradiated in two passes under the beam to achieve a total absorbed dose of 140 kGy. For the second pass, the conveyor belt motion was reversed as soon as the pucks were out of the electron beam raster area to avoid any heat loss from the pucks. Following the warm irradiation, 15 pucks were heated to 150° C. for 2 hours so as to obtain complete melting of the crystals and substantial elimination of the free radicals.
  • A. Thermal Properties (DSC) of the Specimens Prepared in Example 16
  • A Perkin-Elmer DSC 7 was used with an ice water heat sink and a heating and cooling rate of 10° C./min with a continuous nitrogen purge. The crystallinity of the samples obtained from Example 16 was calculated from the weight of the sample and the heat of melting of polyethylene crystals (69.2 cal/gm). The temperature corresponding to the peak of the endotherm was taken as the melting point. In the case of multiple endotherm peaks, multiple melting points were reported.
  • Table 18 shows the variations obtained in the melting behavior and crystallinity of the polymer as a function of depth away from the e-beam incidence surface. FIG. 8 shows representative DSC melting endotherms obtained at 2 cm below the surface of e-beam incidence obtained both before and after the subsequent melting.
    TABLE 18
    WIR-AM GUR 4050 barstock, Total dose = 140 kGy, 75 kGy/pass
    T 1st peak T 2nd peak T 3rd peak T 1st peak T 2nd peak Crystallinity Crystallinity
    after after after after after after after
    irradiation irradiation irradiation subsequent subsequent irradiation subsequent
    Depth (mm) (° C.) (° C.) (° C.) melting (° C.) melting (° C.) (%) melting (%)
    1.77 109.70 NP 145.10 116.35 139.45 53.11 45.26
    5.61 118.00 NP 147.80 117.10 141.60 52.61 45.46
    9.31 113.00 NP 146.40 117.30 141.10 50.13 44.42
    13.11 113.47 138.07 145.23 116.03 139.83 47.29 43.33
    16.89 113.40 137.40 144.80 115.90 139.30 47.68 43.05
    20.95 113.70 138.33 145.17 115.17 139.63 44.99 43.41
    24.60 112.40 134.20 143.90 114.90 138.70 49.05 44.40
    28.57 112.30 NP 145.70 115.90 139.90 50.84 44.40
    31.89 111.20 NP 144.50 114.90 138.80 51.88 45.28
    34.95 NP NP 143.90 112.00 138.45 50.09 45.36
    39.02 NP NP 139.65 114.95 138.30 49.13 46.03

    *NP: The peak is not present
  • These results indicate that the melting behavior of UHMWPE changes drastically after the subsequent melting step in this embodiment of the WIR-AM process. Before the subsequent melting, the polymer exhibited three melting peaks, while after subsequent melting it exhibited two melting peaks.
  • B. Electron Paramagnetic Resonance (EPR) of the Specimens Prepared in Example 16
  • EPR was performed at room temperature on samples obtained from Example 16 after placing the samples in an air tight quartz tube in a nitrogen atmosphere. The instrument used was the Bruker ESP 300 EPR spectrometer and the tubes uses were Taperlok EPR sample tubes (obtained from Wilmad Glass Co., Buena, N.J.).
  • The unirradiated samples did not have any detectable free radicals in them. During the process of irradiation, free radicals are created which can last for at least several years under the appropriate conditions.
  • Before the subsequent melting, the EPR results showed a complex free radical peak composed of both peroxy and primary free radicals. After the subsequent melting the EPR free radical signal was reduced to undetectable levels. These results indicated that the free radicals induced by the irradiation process were substantially eliminated after the subsequent melting step. Thus, the UHMWPE was highly resistant to oxidation.
  • Example 17
  • II. Method of Making UHMWPE Using Warm Irradiation and Partial Adiabatic Melting with Subsequent Complete Melting (WIR-AM)
  • This example illustrates a method of making UHMWPE that has a cross-linked structure, exhibits two distinct melting endotherms in DSC, and has substantially no detectable free radicals, by irradiating UHMWPE that has been heated to below the melting point so as to generate the adiabatic partial melting of the UHMWPE and by subsequently melting the UHMWPE.
  • A GUR 4020 bar stock (made from ram extruded Hoescht Celanese GUR 4020 resin obtained from Westlake Plastics, Lenni, Pa.) was machined into 8.5 cm diameter and 4 cm thick hockey pucks. Twenty-five pucks, 25 aluminum holders and 25 20 cm×20 cm fiberglass blankets were preheated to 125° C. overnight in an air convection oven. The preheated pucks were each placed in a preheated aluminum holder which was covered by a preheated fiberglass blanket to minimize heat loss to the surroundings during irradiation. The pucks were then irradiated in air using a 10 MeV, 1 kW electron beam with a scan width of 30 cm (AECL, Pinawa, Manitoba, Canada). The conveyor speed was 0.07 cm/sec which gave a dose rate of 70 kGy per pass. The pucks were irradiated in two passes under the beam to achieve a total absorbed dose of 140 kGy. For the second pass, the conveyor belt motion was reversed as soon as the pucks were out of the electron beam raster area to avoid any heat loss from the pucks. Following the warm irradiation, 15 pucks were heated to 150° C. for 2 hours so as to obtain complete melting of the crystals and substantial elimination of the free radicals.
  • Example 18
  • III. Method of Making UHMWPE Using Warm Irradiation and Partial Adiabatic Melting with Subsequent Complete Melting (WIR-AM)
  • This example illustrates a method of making UHMWPE that has a cross-linked structure, exhibits two distinct melting endotherms in DSC, and has substantially no detectable free radicals, by irradiating UHMWPE that has been heated to below the melting point so as to generate adiabatic partial melting of the UHMWPE and by subsequently melting the UHMWPE.
  • A GUR 1050 bar stock (made from ram-extruded Hoescht Celanese GUR 1050 resin obtained from Westlake Plastics, Lenni, Pa.) was machined into 8.5 cm diameter and 4 cm thick hockey pucks. Eighteen pucks, 18 aluminum holders and 18 20 cm×20 cm fiberglass blankets were preheated to 125° C., 90° C., or 70° C., in an air convection oven overnight. Six pucks were used for each different pre-heat temperature. The preheated pucks were each placed in a preheated aluminum holder which was covered by a preheated fiberglass blanket to minimize heat loss to the surroundings during irradiation. The pucks were then irradiated in air using a 10 MeV and 1 kW electron beam with a scan width of 30 cm (AECL, Pinawa, Manitoba, Canada). The conveyer speed was 0.06 cm/sec which gave a dose rate of 75 kGy per pass. The pucks were irradiated in two passes under the beam to accumulate a total of 150 kGy of absorbed dose. For the second pass, the conveyor belt motion was reversed as soon as the pucks were out of the electron beam raster area to avoid any heat loss from the pucks. Following the warm irradiation, half of the pucks were heated to 150° C. for 2 hours so as to obtain complete melting of the crystals and substantial elimination of the free radicals.
  • A. Thermal Properties of the Specimens Prepared in Example 18
  • A Perkin-Elmer DSC 7 was used with an ice water heat sink and a heating and cooling rate of 10° C./min with a continuous nitrogen purge. The crystallinity of the samples obtained from Example 18 was calculated from the weight of the sample and the heat of melting of polyethylene crystals (69.2 cal/gm). The temperature corresponding to the peak of the endotherm was taken as the melting point. In the case of multiple endotherm peaks, multiple melting points were reported.
  • Table 19 shows the effect of pre-heat temperature on the melting behavior and crystallinity of the polymer. FIG. 9 shows the DSC profile of a puck processed with the WIR-AM method at a pre-heat temperature of 125° C. both before and after subsequent melting.
    TABLE 19
    WIR-AM GUR 1050 barstock, Total dose = 150 kGy, 75 kGy/pass
    T 1st peak T 2nd peak
    T 1st peak T 2nd peak T 3rd peak after after Crystallinity Crystallinity
    after after after subsequent subsequent after after
    Preheat irradiation irradiation irradiation melting melting irradiation subsequent
    (° C.) (° C.) (° C.) (° C.) (° C.) (° C.) (%) melting (%)
    125 114.6 135.70 143.5 114.85 135.60 42.81 40.85
    90 NP 142.85 NP 116.75 136.95 52.39 44.31
    70 NP 141.85 NP NP 136.80 51.59 44.62

    *NP: The peak is not present
  • These results indicate that the melting behavior of UHMWPE changes drastically after the subsequent melting step in this embodiment of the WIR-AM process. Before the subsequent melting, the polymer exhibited three melting peaks, while after subsequent melting it exhibited two melting peaks.
  • Example 19
  • IV. Method of Making UHMWPE Using Warm Irradiation and Partial Adiabatic Melting with Subsequent Complete Melting (WIR-AM)
  • This example illustrates a method of making UHMWPE that has a cross-linked structure, exhibits two distinct melting endotherms in DSC, and has substantially no detectable free radicals, by irradiating UHMWPE that has been heated to below the melting point so as to generate adiabatic partial melting of the UHMWPE and by subsequently melting the polymer.
  • A GUR 1020 bar stock (made from ram extruded Hoescht Celanese GUR 1020 resin obtained from Westlake Plastics, Lenni, Pa.) was machined in 7.5 cm diameter and 4 cm thick hockey pucks. Ten pucks, 10 aluminum holders and 10 20 cm×20 cm fiberglass blankets were preheated to 125° C. overnight in an air convection oven. The preheated pucks were each placed in a preheated aluminum holder which was covered by a preheated fiberglass blanket to minimize heat loss to the surroundings during irradiation. The pucks were then irradiated in air using a 10 MeV, 1 kW linear electron beam accelerator (AECL, Pinawa, Manitoba, Canada). The scan width and the conveyor speed was adjusted to achieve the desired dose rate per pass. The pucks were then irradiated to 61, 70, 80, 100, 140, and 160 kGy of total absorbed dose. For 61, 70, 80 kGy absorbed dose, the irradiation was completed in one pass; while for 100, 140, and 160 it was completed in two passes. For each absorbed dose level, six pucks were irradiated. During the two pass experiments, for the second pass, the conveyor belt motion was reversed as soon as the pucks were out of the electron beam raster area to avoid any heat loss from the pucks. Following the irradiation, half of the pucks were heated to 150° C. for 2 hours in an air convection oven so as to obtain complete melting of the crystals and substantial elimination of the free radicals.
  • Example 20
  • V. Method of Making UHMWPE Using Warm Irradiation and Partial Adiabatic Melting with Subsequent Complete Melting (WIR-AM)
  • This example illustrates a method of making UHMWPE that has a cross-linked structure, exhibits two distinct melting endotherms in DSC, and has substantially no detectable free radicals, by irradiating UHMWPE that has been heated to below the melting point so as to generate adiabatic partial melting of the UHMWPE and by subsequently melting the polymer.
  • A GUR 4150 bar stock (made from ram extruded Hoescht Celanese GUR 4150 resin obtained from Westlake Plastics, Lenni, Pa.) was machined into 7.5 cm diameter and 4 cm thick hockey pucks. Ten pucks, 10 aluminum holders and 10 20 cm×20 cm fiberglass blankets were preheated to 125° C. overnight in an air convection oven. The preheated pucks were each placed in a preheated aluminum holder which was covered by a preheated fiberglass blanket to minimize heat loss to the surroundings during irradiation. The pucks were then irradiated in air using a 10 MeV, 1 kW linear electron beam accelerator (AECL, Pinawa, Manitoba, Canada). The scan width and the conveyor speed was adjusted to achieve the desired dose rate per pass. The pucks were irradiated to 61, 70, 80, 100, 140, and 160 kGy of total absorbed dose. For each absorbed dose level, six pucks were irradiated. For 61, 70, 80 kGy absorbed dose, the irradiation was completed in one pass; for 100, 140 and 160 kGy, it was completed in two passes.
  • Following the irradiation, three pucks out of each different absorbed dose level were heated to 150° C. for 2 hours to completely melt the crystals and reduce the concentration of free radicals to undetectable levels.
  • A. Properties of the Specimens Prepared in Example 20
  • A Perkin-Elmer DSC 7 was used with an ice water heat sink and a heating and cooling rate of 10° C. per minute with a continuous nitrogen purge. The crystallinity of the samples obtained from Example 20 was calculated from the weight of the sample and the heat of melting of polyethylene crystals (69.2 cal/gm). The temperature corresponding to the peak of the endotherm was taken as the melting point. In the case of multiple endotherm peaks, multiple melting points were reported.
  • The results obtained are shown in Table 20 as a function of total absorbed dose level. They indicate that crystallinity decreases with increasing dose level. At the absorbed dose levels studied, the polymer exhibited two melting peaks (T1=˜118° C., T2=˜137° C.) after the subsequent melting step.
    TABLE 20
    WIR-AM GUR 4150 barstock
    T 1st peak T 2nd peak T 3rd peak T 1st peak T 2nd peak Crystallinity Crystallinity
    after after after after after after after
    Irradiation irradiation irradiation irradiation subsequent subsequent irradiation subsequent
    dose (kGy) (° C.) (° C.) (° C.) melting (° C.) melting (° C.) (%) melting (%)
    160 113.4 135.10 143.20 114 135.90 41.97 39.58
    140 114.6 135.10 143.60 116.2 138.60 45.25 41.51
    100 118.7 125.10 143.50 118.2 138.20 47.18 42.58
    80 115.7 NP 142.00 119.1 137.60 50.61 44.52
    70 114.8 NP 141.40 118.9 137.00 52.36 44.95
    61 114.6 NP 140.20 119.1 136.00 53.01 45.04

    *NP: The peak is not present
  • Example 21
  • Temperature Rise During WIR-AM Process
  • This example demonstrates that the temperature rises during the warm irradiation process leading to adiabatic partial or complete melting of the UHMWPE.
  • A GUR 4150 bar stock (made from ram extruded Hoescht Celanese GUR 4150 resin obtained from Westlake Plastics, Lenni, Pa.) was machined into a 8.5 cm diameter and 4 cm thick hockey puck. One hole was drilled into the body-center of the puck. A Type K thermocouple was placed in this hole. The puck was pre-heated to 130° C. in air convection oven. The puck was then irradiated using 10 MeV, 1 kW electron beam (AECL, Pinawa, Manitoba, Canada). The irradiation was carried out in air with a scan width of 30 cm. The dose rate was 27 kGy/min and the puck was left stationary under the beam. The temperature of the puck was constantly measured during irradiation.
  • FIG. 11 shows the temperature rise in the puck obtained during the irradiation process. Initially, the temperature is at the pre-heat temperature (130° C.). As soon as the beam is turned on, the temperature increases, during which time the UHMWPE crystals melt. There is melting of smaller size crystals starting from 130° C., indicating that partial melting occurs during the heating. At around 145° C. where there is an abrupt change in the heating behavior, complete melting is achieved. After that point, temperature continues to rise in the molten material.
  • This example demonstrates that during the WIR-AM process, the absorbed dose level (duration of irradiation) can be adjusted to either partially or completely melt the polymer. In the former case, the melting can be completed with an additional melting step in an oven to eliminate the free radicals.
  • Example 22
  • Method of Making UHMWPE Using Cold Irradiation and Adiabatic Heating with Subsequent Complete Melting (CIR-AM)
  • This example illustrates a method of making UHMWPE that has a cross-linked structure, and has substantially no detectable free radicals, by irradiating UHMWPE at a high enough dose rate to generate adiabatic heating of the UHMWPE and by subsequently melting the polymer.
  • A GUR 4150 bar stock (made from ram extruded Hoescht Celanese GUR 4150 resin obtained from Westlake Plastics, Lenni, Pa.) was machined into 8.5 cm diameter and 4 cm thick hockey pucks. Twelve pucks were irradiated stationary, in air, at a dose rate of 60 kGy/min using 10 MeV, 30 kW electrons (E-Beam Services, Cranbury, N.J.). Six of the pucks were irradiated to a total dose of 170 kGy, while the other six were irradiated to a total dose of 200 kGy. At the end of the irradiation the temperature of the pucks was greater than 100° C.
  • Following the irradiation, one puck of each series was heated to 150° C. for 2 hours to melt all the crystals and reduce the concentration of free radicals to undetectable levels.
  • A. Thermal Properties of the Specimens Prepared in Example 22
  • A Perkin-Elmer DSC 7 was used with an ice water heat sink and a heating and cooling rate of 10° C. per minute with a continuous nitrogen purge. The crystallinity of the samples obtained from Example 22 was calculated from the weight of the sample and the heat of melting of polyethylene crystals (69.2 cal/gm). The temperature corresponding to the peak of the endotherm was taken as the melting point.
  • Table 21 summarizes the effect of total absorbed dose on the thermal properties of CIR-AM UHMWPE both before and after the subsequent melting process. The results obtained indicate one single melting peak both before and after the subsequent melting step.
    TABLE 21
    CIR-AM GUR 4150 barstock
    Crystallinity Crystallinity
    T peak after T peak after after after
    Irradiation irradiation subsequent irradiation subsequent
    dose (kGy) (° C.) melting (° C.) (%) melting (%)
    170 143.67 137.07 58.25 45.27
    200 143.83 136.73 54.74 43.28
  • Example 23
  • Comparison of Tensile Deformation Behavior of Unirradiated UHMWPE, Cold-Irradiated and Subsequently Melted UHMWPE (CIR-SM), and Warm Irradiated and Partially Adiabatic Melted and Subsequently Melted UHMWPE (WIR-AM)
  • This example compares the tensile deformation behavior of UHMWPE in its unirradiated form, and irradiated forms via CIR-SM and WIR-AM methods.
  • The ASTM D638 Type V standard was used to prepare dog bone specimens for the tensile test. The tensile test was carried out on an Instron 4120 Universal Tester at a cross-head speed of 10 mm/min. The engineering stress-strain behavior was calculated from the load-displacement data following ASTM D638.
  • The dog bone specimens were machined from GUR 4150 hockey pucks (made from ram extruded Hoescht Celanese GUR 4150 resin obtained from Westlake Plastics, Lenni, Pa.) that were treated by CIR-SM and WIR-AM methods. For the CIR-SM, the method described in Example 8 was followed, while for WIR-AM, the method described in Example 17 was followed. In both cases, the total dose administered was 150 kGy.
  • FIG. 12 shows the tensile behavior obtained for the unirradiated control, CIR-SM treated, and WIR-AM treated specimens. It shows the variation in tensile deformation behavior in CIR-SM and WIR-AM treated UHMWPE, even though in both methods the irradiation was carried out to 150 kGy.
  • Those skilled in the art will be able to ascertain using no more than routine experimentation, many equivalents of the specific embodiments of the invention described herein. These and all other equivalents are intended to be encompassed by the following claims.

Claims (19)

  1. 1. A medical prosthesis for use within the body, said prosthesis being formed of radiation treated ultra high molecular weight polyethylene having substantially no detectable free radicals.
  2. 2-123. (canceled)
  3. 124. An implantable bearing component made by the process comprising the steps of:
    (a) crosslinking, by irradiation, a preformed polymer in its solid state;
    (b) remelting the crosslinked polymer; and
    (c) fashioning the implantable bearing component from the crosslinked and remelted polymer, wherein the polymer is selected from the group consisting of: polyester, poly(methylmethacrylate), nylon, polycarbonates, and polyhydrocarbons.
  4. 125. The implantable bearing component of claim 124, wherein the polymer is crosslinked by gamma radiation at a dose of from about 1 to about 100 Mrad.
  5. 126. The implantable bearing component of claim 125, wherein the gamma radiation dose is from about 4.5 to about 25 Mrad.
  6. 127. The implantable bearing component of claim 126, wherein the gamma radiation dose is from about 4.5 to about 10 Mrad.
  7. 128. The implantable bearing component of claim 127, wherein the implantable bearing component is for use in a joint prosthesis.
  8. 129. The implantable bearing component of claim 128, wherein the joint prosthesis is selected from the group consisting of: hip, knee, ankle, elbow, jaw, shoulder, finger and spine joint prostheses.
  9. 130. The implantable bearing component of claim 129, wherein the joint prosthesis is selected from the group consisting of: hip and knee joint prostheses.
  10. 131. The implantable bearing component of claim 124, wherein the implantable bearing component is for use in a joint prosthesis.
  11. 132. The implantable bearing component of claim 124, wherein the implantable bearing component is selected from the group consisting of: an acetabular cup, an insert of an acetabular cup, and a liner of an acetabular cup.
  12. 133. A joint prosthesis comprising:
    a first member adapted to be secured to a first bone constituting a first portion of a joint;
    an articulating surface on the first member;
    a second member adapted to be secured to a second bone constituting a second portion of the joint; and
    the implantable bearing component of claim 124, said implantable bearing component being adapted for disposition between the second member and the articulating surface, said implantable bearing component being adapted to receive said articulating surface for movement therein.
  13. 134. The joint prosthesis of claim 133, wherein the joint prosthesis is selected from the group consisting of: hip, knee, ankle, elbow, jaw, shoulder, finger and spine joint prostheses.
  14. 135. The joint prosthesis of claim 134, wherein the joint prosthesis is selected from the group consisting of: hip and knee joint prostheses.
  15. 136. The joint prosthesis of claim 133, wherein the joint prosthesis is for use in a hip joint replacement wherein:
    (a) the first bone is a femur;
    (b) the second bone is a pelvic bone;
    (c) the first member is a prosthetic stem;
    (d) the second member is a prosthetic acetabular shell;
    (e) the articulating surface is a prosthetic femoral head; and
    (f) the implantable bearing component is selected from the group consisting of: an acetabular cup liner and an acetabular cup insert.
  16. 137. The joint prosthesis of claim 133, wherein said articulating surface and said first member are separate units.
  17. 138. The joint prosthesis of claim 133, wherein the implantable bearing component is made of polyethylene.
  18. 139. The joint prosthesis of claim 136, wherein the implantable bearing component is made of polyethylene.
  19. 140. A joint prosthesis comprising:
    a first member adapted to be secured to a first bone constituting a first portion of the joint;
    an articulating surface on the first member;
    the implantable bearing component of claim 124 adapted to be secured to a second bone constituting a second portion of the joint, said implantable bearing component being adapted to receive said articulating surface for movement therein.
US11184803 1996-02-13 2005-07-20 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices Abandoned US20050267594A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US08600744 US5879400A (en) 1996-02-13 1996-02-13 Melt-irradiated ultra high molecular weight polyethylene prosthetic devices
US72631396 true 1996-10-02 1996-10-02
US79863897 true 1997-02-11 1997-02-11
US57232400 true 2000-05-18 2000-05-18
US09764445 US8865788B2 (en) 1996-02-13 2001-01-19 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US11184803 US20050267594A1 (en) 1996-02-13 2005-07-20 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11184803 US20050267594A1 (en) 1996-02-13 2005-07-20 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US12333572 US20090105364A1 (en) 1996-02-13 2008-12-12 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09764445 Continuation US8865788B2 (en) 1996-02-13 2001-01-19 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12333572 Continuation US20090105364A1 (en) 1996-02-13 2008-12-12 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices

Publications (1)

Publication Number Publication Date
US20050267594A1 true true US20050267594A1 (en) 2005-12-01

Family

ID=27416815

Family Applications (14)

Application Number Title Priority Date Filing Date
US09764445 Expired - Lifetime US8865788B2 (en) 1996-02-13 2001-01-19 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US09842166 Expired - Lifetime US6786933B2 (en) 1996-02-13 2001-04-26 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US10197209 Abandoned US20030119935A1 (en) 1996-02-13 2002-07-18 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US10197208 Abandoned US20030013781A1 (en) 1996-02-13 2002-07-18 Radiation and melt treated ultra high molecular weight polyethylene prosthetic device
US10197263 Abandoned US20030105182A1 (en) 1996-02-13 2002-07-18 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US10696709 Abandoned US20050010288A1 (en) 1996-02-13 2003-10-30 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US10696362 Abandoned US20040132856A1 (en) 1996-02-13 2003-10-30 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US10901089 Expired - Lifetime US7858671B2 (en) 1996-02-13 2004-07-29 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US10948440 Abandoned US20050056971A1 (en) 1996-02-13 2004-09-24 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US11007358 Abandoned US20050096749A1 (en) 1996-02-13 2004-12-09 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US11184803 Abandoned US20050267594A1 (en) 1996-02-13 2005-07-20 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US12333572 Abandoned US20090105364A1 (en) 1996-02-13 2008-12-12 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US12977391 Expired - Lifetime US8263676B2 (en) 1996-02-13 2010-12-23 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US13295642 Abandoned US20120060852A1 (en) 1996-02-13 2011-11-14 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices

Family Applications Before (10)

Application Number Title Priority Date Filing Date
US09764445 Expired - Lifetime US8865788B2 (en) 1996-02-13 2001-01-19 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US09842166 Expired - Lifetime US6786933B2 (en) 1996-02-13 2001-04-26 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US10197209 Abandoned US20030119935A1 (en) 1996-02-13 2002-07-18 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US10197208 Abandoned US20030013781A1 (en) 1996-02-13 2002-07-18 Radiation and melt treated ultra high molecular weight polyethylene prosthetic device
US10197263 Abandoned US20030105182A1 (en) 1996-02-13 2002-07-18 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US10696709 Abandoned US20050010288A1 (en) 1996-02-13 2003-10-30 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US10696362 Abandoned US20040132856A1 (en) 1996-02-13 2003-10-30 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US10901089 Expired - Lifetime US7858671B2 (en) 1996-02-13 2004-07-29 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US10948440 Abandoned US20050056971A1 (en) 1996-02-13 2004-09-24 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US11007358 Abandoned US20050096749A1 (en) 1996-02-13 2004-12-09 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices

Family Applications After (3)

Application Number Title Priority Date Filing Date
US12333572 Abandoned US20090105364A1 (en) 1996-02-13 2008-12-12 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US12977391 Expired - Lifetime US8263676B2 (en) 1996-02-13 2010-12-23 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US13295642 Abandoned US20120060852A1 (en) 1996-02-13 2011-11-14 Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices

Country Status (1)

Country Link
US (14) US8865788B2 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090306781A1 (en) * 2006-02-06 2009-12-10 Masayuki Kyomoto High Wear-Resistant Bearing Material and Artificial Joint Replacement Using the Same
US20100029858A1 (en) * 2007-04-10 2010-02-04 Zimmer, Inc. Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
US7846376B2 (en) 2005-08-18 2010-12-07 Zimmer Gmbh Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles
US7858671B2 (en) 1996-02-13 2010-12-28 The General Hospital Corporation Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US20110153025A1 (en) * 2009-12-21 2011-06-23 Mcminn Derek J Method of Forming a Polymer Component
US8003709B2 (en) * 1996-07-09 2011-08-23 Orthopaedic Hospital Crosslinking of polyethylene for low wear using radiation and thermal treatments
US8399535B2 (en) 2010-06-10 2013-03-19 Zimmer, Inc. Polymer [[s]] compositions including an antioxidant
US8563623B2 (en) 1996-02-13 2013-10-22 The General Hospital Corporation Radiation melt treated ultra high molecular weight polyethylene prosthetic devices
US8652212B2 (en) 2008-01-30 2014-02-18 Zimmer, Inc. Orthopedic component of low stiffness
US8664290B2 (en) 2007-04-10 2014-03-04 Zimmer, Inc. Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
US9708467B2 (en) 2013-10-01 2017-07-18 Zimmer, Inc. Polymer compositions comprising one or more protected antioxidants
US9745462B2 (en) 2008-11-20 2017-08-29 Zimmer Gmbh Polyethylene materials

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE44762E1 (en) 1994-09-21 2014-02-11 Bmg Incorporated Ultra high molecular weight polyethylene molded article for artificial joints and method of preparing the same
CA2166450C (en) * 1995-01-20 2008-03-25 Ronald Salovey Chemically crosslinked ultrahigh molecular weight polyethylene for artificial human joints
WO2001080778A1 (en) * 2000-04-27 2001-11-01 The Orthopaedic Hospital Oxidation-resistant and wear-resistant polyethylenes for human joint replacements and methods for making them
GB0027210D0 (en) * 2000-11-07 2000-12-27 Benoist Girard & Cie Prosthesis bearing component
GB0027211D0 (en) 2000-11-07 2000-12-27 Benoist Girard & Cie Cementless prosthesis bearing element
US6800350B2 (en) * 2001-05-18 2004-10-05 Koninklijke Philips Electronics N.V. Moisture-absorption sheet
US7160492B2 (en) * 2001-12-12 2007-01-09 Depuy Products, Inc. Orthopaedic device for implantation in the body of an animal and method for making the same
EP1463457A4 (en) * 2002-01-04 2006-12-20 Massachusetts Gen Hospital A high modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US7819925B2 (en) * 2002-01-28 2010-10-26 Depuy Products, Inc. Composite prosthetic bearing having a crosslinked articulating surface and method for making the same
WO2004032987A1 (en) * 2002-10-11 2004-04-22 Cartificial A/S Medical device comprising a bio-compatible polymeric product with a layered structure
FR2847453B1 (en) * 2002-11-22 2005-09-23 Jean Francois Biegun Ancillaries, including rape or cutting block, a single-use kit including ancillary and method of manufacture
WO2004064618B1 (en) * 2003-01-16 2005-07-14 Massachusetts Gen Hospital Methods for making oxidation resistant polymeric material
US7938861B2 (en) 2003-04-15 2011-05-10 Depuy Products, Inc. Implantable orthopaedic device and method for making the same
US20040262809A1 (en) * 2003-06-30 2004-12-30 Smith Todd S. Crosslinked polymeric composite for orthopaedic implants
US20050050854A1 (en) * 2003-09-09 2005-03-10 Jean-Pascal Zambaux Sterile, pyrogen-free, polymeric film-based heating bag
US7384430B2 (en) * 2004-06-30 2008-06-10 Depuy Products, Inc. Low crystalline polymeric material for orthopaedic implants and an associated method
US7547405B2 (en) 2004-10-07 2009-06-16 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
US7462318B2 (en) * 2004-10-07 2008-12-09 Biomet Manufacturing Corp. Crosslinked polymeric material with enhanced strength and process for manufacturing
US8262976B2 (en) 2004-10-07 2012-09-11 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
US7344672B2 (en) 2004-10-07 2008-03-18 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
WO2006063199A3 (en) * 2004-12-09 2007-07-19 The Foundry Inc Aortic valve repair
DE102005020863A1 (en) * 2005-05-02 2006-11-09 Merck Patent Gmbh Composite material with reduced abrasion
US7803310B2 (en) * 2005-06-14 2010-09-28 Omni Life Science, Inc. Crosslinked polyethylene article
US7538379B1 (en) * 2005-06-15 2009-05-26 Actel Corporation Non-volatile two-transistor programmable logic cell and array layout
EP2420526B1 (en) * 2005-08-22 2016-06-29 The General Hospital Corporation Oxidation resistant homogenized polymeric material
US8579985B2 (en) 2006-12-07 2013-11-12 Ihip Surgical, Llc Method and apparatus for hip replacement
US8974540B2 (en) 2006-12-07 2015-03-10 Ihip Surgical, Llc Method and apparatus for attachment in a modular hip replacement or fracture fixation device
US8187280B2 (en) 2007-10-10 2012-05-29 Biomet Manufacturing Corp. Knee joint prosthesis system and method for implantation
US8163028B2 (en) 2007-01-10 2012-04-24 Biomet Manufacturing Corp. Knee joint prosthesis system and method for implantation
JP5448842B2 (en) 2007-01-10 2014-03-19 バイオメト マニファクチャリング コーポレイションBiomet Manufacturing Corp. Knee joint prosthesis system and embedding method
US8562616B2 (en) 2007-10-10 2013-10-22 Biomet Manufacturing, Llc Knee joint prosthesis system and method for implantation
US8328873B2 (en) 2007-01-10 2012-12-11 Biomet Manufacturing Corp. Knee joint prosthesis system and method for implantation
WO2008101073A3 (en) * 2007-02-14 2008-12-04 Anuj Bellare Crosslinked polymers
US8641959B2 (en) 2007-07-27 2014-02-04 Biomet Manufacturing, Llc Antioxidant doping of crosslinked polymers to form non-eluting bearing components
JP4806717B2 (en) * 2009-06-25 2011-11-02 株式会社沖データ Image processing system
US8230257B2 (en) * 2009-06-26 2012-07-24 Seagate Technology Llc Systems, methods and devices for controlling backup power provided to memory devices and used for storing of sensitive data
CN103491900B (en) 2010-12-23 2017-03-01 托尔福公司 For mitral valve repair and replacement of system
CN107647939A (en) 2011-06-21 2018-02-02 托尔福公司 Prosthetic heart valve devices and associated systems and methods
CN103997978A (en) 2011-07-13 2014-08-20 通用医疗公司 Methods and devices for knee joint replacement with anterior cruciate ligament substitution
US9655722B2 (en) 2011-10-19 2017-05-23 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9763780B2 (en) 2011-10-19 2017-09-19 Twelve, Inc. Devices, systems and methods for heart valve replacement
US10016271B2 (en) 2011-10-19 2018-07-10 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9039757B2 (en) 2011-10-19 2015-05-26 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
CN102490308A (en) * 2011-12-26 2012-06-13 华东理工大学 Preparation method of absorbent composite internal fixator
US8865051B1 (en) * 2012-01-24 2014-10-21 Mercury Plastics, Inc. Method of making a crosslinked overmolded assembly
US9579198B2 (en) 2012-03-01 2017-02-28 Twelve, Inc. Hydraulic delivery systems for prosthetic heart valve devices and associated methods
GB2507640B (en) 2012-09-10 2015-08-26 Acumed Llc Radial head prosthesis with floating articular member
EP2900179A4 (en) 2012-09-27 2016-12-21 The General Hospital Corp D/B/A Massachusetts General Hospital Femoral heads, mobile inserts, acetabular components, and modular junctions for orthopedic implants and methods of using femoral heads, mobile inserts, acetabular components, and modular junctions for orthopedic implants
US9586370B2 (en) 2013-08-15 2017-03-07 Biomet Manufacturing, Llc Method for making ultra high molecular weight polyethylene
JP2016204705A (en) * 2015-04-22 2016-12-08 キヤノントッキ株式会社 Film deposition apparatus, and film deposition method
US9763792B2 (en) 2015-10-01 2017-09-19 Acumed Llc Radial head prosthesis with rotate-to-lock interface
WO2017192347A1 (en) 2016-05-02 2017-11-09 The General Hospital Corporation Implant surfaces for pain control

Citations (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3297641A (en) * 1964-01-17 1967-01-10 Grace W R & Co Process for cross-linking polyethylene
US3352818A (en) * 1964-01-31 1967-11-14 Glanzstoff Ag Stability of polyolefines
US3698017A (en) * 1969-08-11 1972-10-17 Nat Res Dev Prosthetic acetabular devices
US3758273A (en) * 1970-04-03 1973-09-11 Gillette Co Processes for sterilizing polypropylene objects
US3944536A (en) * 1973-06-18 1976-03-16 E. I. Du Pont De Nemours & Company Exceptionally rigid and tough ultrahigh molecular weight linear polyethylene
US4281420A (en) * 1979-02-15 1981-08-04 Raab S Bone connective prostheses adapted to maximize strength and durability of prostheses-bone cement interface; and methods of forming same
US4385405A (en) * 1979-10-03 1983-05-31 Teinturier Pierre L Hip prosthesis and its method of fitting
US4524467A (en) * 1983-11-21 1985-06-25 Joint Medical Products Corp. Apparatus for constraining a socket bearing in an artificial joint
US4525257A (en) * 1982-12-27 1985-06-25 Union Carbide Corporation Low level irradiated linear low density ethylene/alpha-olefin copolymers and film extruded therefrom
US4535486A (en) * 1981-05-18 1985-08-20 Rensselaer Polytechnic Institute Low friction bearing surfaces and structures particularly for artificial prosthetic joints
US4586995A (en) * 1982-09-17 1986-05-06 Phillips Petroleum Company Polymer and irradiation treatment method
US4655769A (en) * 1984-10-24 1987-04-07 Zachariades Anagnostis E Ultra-high-molecular-weight polyethylene products including vascular prosthesis devices and methods relating thereto and employing pseudo-gel states
US4747990A (en) * 1985-03-12 1988-05-31 Cie Oris Industrie S.A. Process of making a high molecular weight polyolefin part
US4870136A (en) * 1985-11-30 1989-09-26 Mitsui Pertrochemical Industries, Ltd. Molecular oriented, silane-crosslinked ultra-high-molecular-weight polyethylene molded article and process for preparation thereof
US4892552A (en) * 1984-03-30 1990-01-09 Ainsworth Robert D Orthopedic device
US4916198A (en) * 1985-01-31 1990-04-10 Himont Incorporated High melt strength, propylene polymer, process for making it, and use thereof
US4944974A (en) * 1984-10-24 1990-07-31 Zachariades Anagnostis E Composite structures of ultra-high-molecular-weight polymers, such as ultra-high-molecular-weight polyethylene products, and method of producing such structures
US5001008A (en) * 1987-07-21 1991-03-19 Mitsui Petrochemical Industries, Ltd. Reinforcing fibrous material
US5001206A (en) * 1983-12-10 1991-03-19 Stamicarbon B.V. Oriented polyolfins
US5015525A (en) * 1987-12-03 1991-05-14 Mitsui Petrochemical Industries Ltd. Polyolefin fiber having improved initial elongation and process for preparation thereof
US5019105A (en) * 1989-08-03 1991-05-28 Biomet, Inc. Acetabular cup prosthesis assembly
US5024670A (en) * 1989-10-02 1991-06-18 Depuy, Division Of Boehringer Mannheim Corporation Polymeric bearing component
US5037928A (en) * 1989-10-24 1991-08-06 E. I. Du Pont De Nemours And Company Process of manufacturing ultrahigh molecular weight linear polyethylene shaped articles
US5059196A (en) * 1991-03-07 1991-10-22 Dow Corning Wright Corporation Femoral prosthesis holder/driver tool and method of implantation using same
US5066755A (en) * 1984-05-11 1991-11-19 Stamicarbon B.V. Novel irradiated polyethylene filaments tapes and films and process therefor
US5123924A (en) * 1990-04-25 1992-06-23 Spire Corporation Surgical implants and method
US5123925A (en) * 1986-11-06 1992-06-23 Collagen Corporation Gamma irradiation of collagen/mineral mixtures
US5160472A (en) * 1984-10-24 1992-11-03 Zachariades Anagnostis E Method of producing composite structures of ultra-high-molecular-weight polymers, such as ultra-high-molecular-weight polyethylene products
US5160464A (en) * 1983-12-09 1992-11-03 National Research Development Corporation Polymer irradiation
US5358792A (en) * 1991-02-22 1994-10-25 Exxon Chemical Patents Inc. Heat sealable blend of very low density polyethylene or plastomer with polypropylene based polymers and heat sealable film and articles made thereof
US5407623A (en) * 1994-01-06 1995-04-18 Polteco, Inc. Process for obtaining ultra-high modulus line products with enhanced mechanical properties
US5414049A (en) * 1993-06-01 1995-05-09 Howmedica Inc. Non-oxidizing polymeric medical implant
US5428079A (en) * 1990-08-01 1995-06-27 Dsm N.V. Solution of ultra-high molecular weight polyethylene
US5466530A (en) * 1993-01-21 1995-11-14 England; Garry L. Biocompatible components fabricated from a substantially consolidated stock of material
US5478906A (en) * 1988-12-02 1995-12-26 E. I. Du Pont De Nemours And Company Ultrahigh molecular weight linear polyethylene and articles thereof
US5480683A (en) * 1988-05-24 1996-01-02 Nitruvid Process for reducing the coefficient of friction and wear between a metal part and an organic polymer-or copolymer-based part and its application to artificial limb-joints and fittings working in marine environments
US5508319A (en) * 1991-06-21 1996-04-16 Montell North America Inc. High melt strength, ethylene polymer, process for making it, and use thereof
US5515590A (en) * 1994-07-19 1996-05-14 University Of Kentucky Research Foundation Method for reducing the generation of wear particulates from an implant
US5549700A (en) * 1993-09-07 1996-08-27 Ortho Development Corporation Segmented prosthetic articulation
US5549698A (en) * 1993-04-22 1996-08-27 Implex Corp. Prosthetic acetabular cup and method of implant
US5593719A (en) * 1994-03-29 1997-01-14 Southwest Research Institute Treatments to reduce frictional wear between components made of ultra-high molecular weight polyethylene and metal alloys
US5753182A (en) * 1996-02-14 1998-05-19 Biomet, Inc. Method for reducing the number of free radicals present in ultrahigh molecular weight polyethylene orthopedic components
US5824411A (en) * 1993-08-20 1998-10-20 Poly-Med, Inc. Self-reinforced ultra-high molecular weight polyethylene composites
US5869575A (en) * 1995-08-02 1999-02-09 The Dow Chemical Company Ethylene interpolymerizations
US5874123A (en) * 1997-01-24 1999-02-23 Park; Joon B. Precoated polymeric prosthesis and process for making same
US5879400A (en) * 1996-02-13 1999-03-09 Massachusetts Institute Of Technology Melt-irradiated ultra high molecular weight polyethylene prosthetic devices
US5972444A (en) * 1991-10-15 1999-10-26 The Dow Chemical Company Polyolefin compositions with balanced shrink properties
US6005053A (en) * 1996-01-22 1999-12-21 The Dow Chemical Company Polyolefin elastomer blends exhibiting improved properties
US6017975A (en) * 1996-10-02 2000-01-25 Saum; Kenneth Ashley Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance
US6096084A (en) * 1998-09-04 2000-08-01 Biopro, Inc. Modular ball and socket joint preferably with a ceramic head ball
US6165220A (en) * 1996-10-15 2000-12-26 The Orthopaedic Hospital Wear resistant surface-gradient crosslinked polyethylene
US6168626B1 (en) * 1994-09-21 2001-01-02 Bmg Incorporated Ultra high molecular weight polyethylene molded article for artificial joints and method of preparing the same
US6184265B1 (en) * 1999-07-29 2001-02-06 Depuy Orthopaedics, Inc. Low temperature pressure stabilization of implant component
US6228900B1 (en) * 1996-07-09 2001-05-08 The Orthopaedic Hospital And University Of Southern California Crosslinking of polyethylene for low wear using radiation and thermal treatments
US6245276B1 (en) * 1999-06-08 2001-06-12 Depuy Orthopaedics, Inc. Method for molding a cross-linked preform
US6281264B1 (en) * 1995-01-20 2001-08-28 The Orthopaedic Hospital Chemically crosslinked ultrahigh molecular weight polyethylene for artificial human joints
US6355215B1 (en) * 1999-03-10 2002-03-12 Implex Corp. Wear-resistant olefinic medical implant and thermal treatment container therefor
US6506866B2 (en) * 1994-11-17 2003-01-14 Dow Global Technologies Inc. Ethylene copolymer compositions
US6641617B1 (en) * 1996-02-13 2003-11-04 The General Hospital Corp. Radiation and melt treated ultra high molecular weight polyethylene prosthetic device and method
US6786933B2 (en) * 1996-02-13 2004-09-07 The General Hospital Corporation Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US20050043431A1 (en) * 2002-06-06 2005-02-24 Howmedica Osteonics Corp. Sequentially cross-linked polyethylene
US20080215142A1 (en) * 2007-03-02 2008-09-04 The General Hospital Corporation Dba Massachusetts General Hospital Cross-linking of antioxidant-containing polymers
US20080319137A1 (en) * 2007-04-10 2008-12-25 Zimmer, Inc. Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications

Family Cites Families (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE544324A (en) 1955-01-11
US2904480A (en) 1955-06-06 1959-09-15 Grace W R & Co Polyethylene
US2989451A (en) 1955-06-16 1961-06-20 Gen Electric Irradiated polyethylene
US2948666A (en) 1956-11-21 1960-08-09 Gen Electric Irradiation process
US3563869A (en) 1957-11-05 1971-02-16 Grace W R & Co Irradiated polyethylene
US3022543A (en) 1958-02-07 1962-02-27 Grace W R & Co Method of producing film having improved shrink energy
US3200056A (en) 1959-02-13 1965-08-10 Minnesota Mining & Mfg Stabilized polyethylene
US3057791A (en) 1959-07-06 1962-10-09 Phillips Petroleum Co Radiation curing of polymers
US3090770A (en) 1960-04-26 1963-05-21 Grace W R & Co Blended polyethylene compositions of improved clarity and method of making same
GB939096A (en) 1960-11-15 1963-10-09 Ayao Amemiya Irradiation of polymeric materials
US3162623A (en) 1961-12-26 1964-12-22 Du Pont Crosslinking of polymers with nitrogen fluorides
US3362897A (en) 1962-11-21 1968-01-09 Gen Electric Stable irradiated polyethylene
DE1669649B2 (en) 1966-05-27 1971-05-19 A process for the manufacture of finely divided schaumfoermiger olefin polymers with high waermestandfestigkeit
US3832827A (en) 1967-12-18 1974-09-03 J Lemelson Container forming and filling apparatus
US3783115A (en) 1971-07-23 1974-01-01 Cottbus Textilkombinat Process for the radiation treatment of polyethylene
JPS526314B2 (en) 1971-11-01 1977-02-21
US4241463A (en) 1978-10-16 1980-12-30 Precision Cast Specialties, Inc. Prosthetic implant device
WO1980002671A1 (en) 1979-06-06 1980-12-11 Nat Res Dev Polymer processing
US5017627A (en) 1980-10-09 1991-05-21 National Research Development Corporation Composite material for use in orthopaedics
JPS614849B2 (en) 1982-03-12 1986-02-13 Nitto Electric Ind Co
JPS58157830U (en) 1982-04-16 1983-10-21
JPS6346586Y2 (en) 1982-11-02 1988-12-02
JPS59168050U (en) 1983-04-26 1984-11-10
US4587163B1 (en) 1984-03-06 1990-04-03 E Zachariades Anagnostis
DE3582744D1 (en) 1984-03-30 1991-06-13 Nat Res Dev Rohrfoermige belongings.
DE3578399D1 (en) 1984-04-13 1990-08-02 Nat Res Dev A method of deforming in the solid state.
US4950151A (en) 1985-01-31 1990-08-21 Zachariades Anagnostic E Rolling die for producing high modulus products
US4820466A (en) 1985-01-31 1989-04-11 Zachariades Anagnostis E Process for obtaining ultra-high modulus products
DE3545116A1 (en) 1985-05-17 1986-11-20 Transaktor Kb International Bottle for emergency water and methods of making a bottle with emergency water ration
US4701288A (en) 1985-06-05 1987-10-20 Bausch & Lomb Incorporated Method of making articles of dissimilar polymer compositions
NL8502298A (en) 1985-08-21 1987-03-16 Stamicarbon A process for producing polyethylene articles with a high tensile strength and modulus.
JPH0470023B2 (en) 1985-09-27 1992-11-09 Nisso Kk
DE3536204C1 (en) 1985-10-10 1987-06-11 Convent Knabber Gebaeck cooking extruders
JPH0639499B2 (en) 1986-04-17 1994-05-25 日本石油株式会社 Method for manufacturing ultra-high molecular weight polyethylene crosslinked product
GB8620071D0 (en) 1986-08-18 1986-10-01 British Gas Corp Structures of polymeric plastics material
JPS6390515A (en) * 1986-10-03 1988-04-21 Mitsubishi Monsanto Chem Co Production of heat-resistant resin composition
GB2207436B (en) 1987-07-24 1991-07-24 Nat Research And Dev Corp The Solid phase deformation process
BE1001574A6 (en) 1988-04-07 1989-12-05 Flatech Internationa B V B A Orthopaedic and podological material - comprising thermoplastic high density polyethylene contg. silane(s)
US5047446A (en) 1988-07-22 1991-09-10 Himont Incorporated Thermal treatment of irradiated propylene polymer material
US5014494A (en) 1988-09-27 1991-05-14 Sherwood Medical Company Method of sterilizing medical articles
GB8827967D0 (en) 1988-11-30 1989-01-05 Ward I M Die-free drawing
JPH04502028A (en) 1988-12-02 1992-04-09
WO1990006140A1 (en) 1988-12-02 1990-06-14 E.I. Du Pont De Nemours And Company Process of manufacturing ultrahigh molecular weight linear polyethylene shaped articles
US5164464A (en) 1989-01-17 1992-11-17 The Dow Chemical Company Vinyl ester resins containing mesogenic/rigid rodlike moieties
US5030402A (en) 1989-03-17 1991-07-09 Zachariades Anagnostis E Process for producing a new class of ultra-high-molecular-weight polyethylene orthopaedic prostheses with enhanced mechanical properties
US5160677A (en) 1989-12-15 1992-11-03 United States Surgical Corporation Pressurized powder support for treating processes
CA2031406C (en) 1989-12-21 2002-05-28 Paolo Galli Graft copolymers of polyolefins and a method of producing same
US5153039A (en) 1990-03-20 1992-10-06 Paxon Polymer Company, L.P. High density polyethylene article with oxygen barrier properties
US5200439A (en) 1990-04-13 1993-04-06 Mitsui Toatsu Chemicals, Inc. Method for increasing intrinsic viscosity of syndiotactic polypropylene
US5014949A (en) * 1990-06-18 1991-05-14 Goldring Display Group, Inc. Product dispenser
US5352732A (en) 1990-08-07 1994-10-04 E. I. Du Pont De Nemours And Company Homogeneous, high modulus ultrahigh molecular weight polyethylene composites and processes for the preparation thereof
JPH04357440A (en) * 1990-08-20 1992-12-10 Shiseido Co Ltd Photoacoustic cell and photoacoustic measuring apparatus
JPH04185651A (en) 1990-11-21 1992-07-02 Fujikura Ltd Production of crosslinked polyolefin molding
JPH04198242A (en) 1990-11-27 1992-07-17 Komatsu Ltd Ultrahigh-molecular-weight polyethylene composition
US5292584A (en) 1991-04-11 1994-03-08 E. I. Du Pont De Nemours And Company Ultrahigh molecular weight polyethylene and lightly-filled composites thereof
DE69223383D1 (en) * 1991-11-20 1998-01-15 Canon Kk A method for fixing a doctor blade, process cartridge and image forming apparatus
US6123924A (en) * 1991-09-25 2000-09-26 Fisons Plc Pressurized aerosol inhalation compositions
JPH07502290A (en) 1991-11-27 1995-03-09
US5250731A (en) 1992-03-17 1993-10-05 E. I. Du Pont De Nemours And Company Preparation of optically active hydrazines and amines
US5507446A (en) 1993-08-12 1996-04-16 Al-Ro, Inc. Phone cord rewinder
US5446530A (en) * 1994-03-14 1995-08-29 Hughes Aircraft Company Amplitude modulated corrected frequency modulated laser
US5609643A (en) 1995-03-13 1997-03-11 Johnson & Johnson Professional, Inc. Knee joint prosthesis
US5577368A (en) 1995-04-03 1996-11-26 Johnson & Johnson Professional, Inc. Method for improving wear resistance of polymeric bioimplantable components
US8563623B2 (en) 1996-02-13 2013-10-22 The General Hospital Corporation Radiation melt treated ultra high molecular weight polyethylene prosthetic devices
US6174932B1 (en) 1998-05-20 2001-01-16 Denovus Llc Curable sealant composition
JP4198242B2 (en) 1998-10-05 2008-12-17 Ntn株式会社 Wheel bearing unit
US6168625B1 (en) 1998-12-01 2001-01-02 Anthony D. Prescott Adjustable length prosthesis useful for ossicular replacement and reconstruction
DE60028370D1 (en) 1999-04-21 2006-07-06 Howmedica Osteonics Corp A process for producing a selectively cross-linked medical prosthesis from polyethylene, as well as a prosthesis thus prepared
US6432349B1 (en) 1999-06-29 2002-08-13 Zimmer, Inc. Process of making an articulating bearing surface
US6143232A (en) 1999-07-29 2000-11-07 Bristol-Meyers Squibb Company Method of manufacturing an articulating bearing surface for an orthopaedic implant
US6414086B1 (en) 2000-02-29 2002-07-02 Howmedica Osteonics Corp. Compositions, processes and methods of improving the wear resistance of prosthetic medical devices
JP4185651B2 (en) 2000-05-18 2008-11-26 松下電器産業株式会社 Tape-like circuit board conveying apparatus, ics chip assembly, and component mounting apparatus
US6503439B1 (en) 2000-06-15 2003-01-07 Albert H. Burstein Process for forming shaped articles of ultra high molecular weight polyethylene suitable for use as a prosthetic device or a component thereof
GB0027210D0 (en) 2000-11-07 2000-12-27 Benoist Girard & Cie Prosthesis bearing component
US6547828B2 (en) 2001-02-23 2003-04-15 Smith & Nephew, Inc. Cross-linked ultra-high molecular weight polyethylene for medical implant use
CA2619937C (en) * 2005-08-22 2014-10-14 Orhun K. Muratoglu Highly crystalline polyethylene

Patent Citations (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3297641A (en) * 1964-01-17 1967-01-10 Grace W R & Co Process for cross-linking polyethylene
US3352818A (en) * 1964-01-31 1967-11-14 Glanzstoff Ag Stability of polyolefines
US3698017A (en) * 1969-08-11 1972-10-17 Nat Res Dev Prosthetic acetabular devices
US3758273A (en) * 1970-04-03 1973-09-11 Gillette Co Processes for sterilizing polypropylene objects
US3944536A (en) * 1973-06-18 1976-03-16 E. I. Du Pont De Nemours & Company Exceptionally rigid and tough ultrahigh molecular weight linear polyethylene
US4281420A (en) * 1979-02-15 1981-08-04 Raab S Bone connective prostheses adapted to maximize strength and durability of prostheses-bone cement interface; and methods of forming same
US4385405A (en) * 1979-10-03 1983-05-31 Teinturier Pierre L Hip prosthesis and its method of fitting
US4535486A (en) * 1981-05-18 1985-08-20 Rensselaer Polytechnic Institute Low friction bearing surfaces and structures particularly for artificial prosthetic joints
US4586995A (en) * 1982-09-17 1986-05-06 Phillips Petroleum Company Polymer and irradiation treatment method
US4525257A (en) * 1982-12-27 1985-06-25 Union Carbide Corporation Low level irradiated linear low density ethylene/alpha-olefin copolymers and film extruded therefrom
US4524467A (en) * 1983-11-21 1985-06-25 Joint Medical Products Corp. Apparatus for constraining a socket bearing in an artificial joint
US5160464A (en) * 1983-12-09 1992-11-03 National Research Development Corporation Polymer irradiation
US5001206A (en) * 1983-12-10 1991-03-19 Stamicarbon B.V. Oriented polyolfins
US4892552A (en) * 1984-03-30 1990-01-09 Ainsworth Robert D Orthopedic device
US5066755A (en) * 1984-05-11 1991-11-19 Stamicarbon B.V. Novel irradiated polyethylene filaments tapes and films and process therefor
US4655769A (en) * 1984-10-24 1987-04-07 Zachariades Anagnostis E Ultra-high-molecular-weight polyethylene products including vascular prosthesis devices and methods relating thereto and employing pseudo-gel states
US5160472A (en) * 1984-10-24 1992-11-03 Zachariades Anagnostis E Method of producing composite structures of ultra-high-molecular-weight polymers, such as ultra-high-molecular-weight polyethylene products
US4944974A (en) * 1984-10-24 1990-07-31 Zachariades Anagnostis E Composite structures of ultra-high-molecular-weight polymers, such as ultra-high-molecular-weight polyethylene products, and method of producing such structures
US4916198A (en) * 1985-01-31 1990-04-10 Himont Incorporated High melt strength, propylene polymer, process for making it, and use thereof
US4747990A (en) * 1985-03-12 1988-05-31 Cie Oris Industrie S.A. Process of making a high molecular weight polyolefin part
US4902460A (en) * 1985-11-30 1990-02-20 Mitsui Petrochemical Industries, Ltd. Process for preparation of molecularly oriented, silane-crosslinked ultra-high-molecular-weight polyethylene molded article
US4870136A (en) * 1985-11-30 1989-09-26 Mitsui Pertrochemical Industries, Ltd. Molecular oriented, silane-crosslinked ultra-high-molecular-weight polyethylene molded article and process for preparation thereof
US5123925A (en) * 1986-11-06 1992-06-23 Collagen Corporation Gamma irradiation of collagen/mineral mixtures
US5001008A (en) * 1987-07-21 1991-03-19 Mitsui Petrochemical Industries, Ltd. Reinforcing fibrous material
US5015525A (en) * 1987-12-03 1991-05-14 Mitsui Petrochemical Industries Ltd. Polyolefin fiber having improved initial elongation and process for preparation thereof
US5480683A (en) * 1988-05-24 1996-01-02 Nitruvid Process for reducing the coefficient of friction and wear between a metal part and an organic polymer-or copolymer-based part and its application to artificial limb-joints and fittings working in marine environments
US5478906A (en) * 1988-12-02 1995-12-26 E. I. Du Pont De Nemours And Company Ultrahigh molecular weight linear polyethylene and articles thereof
US5684124A (en) * 1988-12-02 1997-11-04 E. I. Du Pont De Nemours And Company Ultrahigh molecular weight linear polyethylene processes of manufacture
US5019105A (en) * 1989-08-03 1991-05-28 Biomet, Inc. Acetabular cup prosthesis assembly
US5024670A (en) * 1989-10-02 1991-06-18 Depuy, Division Of Boehringer Mannheim Corporation Polymeric bearing component
US5037928A (en) * 1989-10-24 1991-08-06 E. I. Du Pont De Nemours And Company Process of manufacturing ultrahigh molecular weight linear polyethylene shaped articles
US5123924A (en) * 1990-04-25 1992-06-23 Spire Corporation Surgical implants and method
US5428079A (en) * 1990-08-01 1995-06-27 Dsm N.V. Solution of ultra-high molecular weight polyethylene
US5358792A (en) * 1991-02-22 1994-10-25 Exxon Chemical Patents Inc. Heat sealable blend of very low density polyethylene or plastomer with polypropylene based polymers and heat sealable film and articles made thereof
US5059196A (en) * 1991-03-07 1991-10-22 Dow Corning Wright Corporation Femoral prosthesis holder/driver tool and method of implantation using same
US5508319A (en) * 1991-06-21 1996-04-16 Montell North America Inc. High melt strength, ethylene polymer, process for making it, and use thereof
US5972444A (en) * 1991-10-15 1999-10-26 The Dow Chemical Company Polyolefin compositions with balanced shrink properties
US5466530A (en) * 1993-01-21 1995-11-14 England; Garry L. Biocompatible components fabricated from a substantially consolidated stock of material
US5549698A (en) * 1993-04-22 1996-08-27 Implex Corp. Prosthetic acetabular cup and method of implant
US6174934B1 (en) * 1993-06-01 2001-01-16 Stryker Technologies Corporation Non-oxidizing polymeric medical implant
US5543471A (en) * 1993-06-01 1996-08-06 Howmedica Inc. Non-oxidizing polymeric medical implant
US5728748A (en) * 1993-06-01 1998-03-17 Howmedica Inc. Non oxidizing polymeric medical implant
US5414049A (en) * 1993-06-01 1995-05-09 Howmedica Inc. Non-oxidizing polymeric medical implant
US5449745A (en) * 1993-06-01 1995-09-12 Howmedica Inc. Non-oxidizing polymeric medical implant
US5650485A (en) * 1993-06-01 1997-07-22 Howmedica Inc. Non-oxidizing polymeric medical implant
US5824411A (en) * 1993-08-20 1998-10-20 Poly-Med, Inc. Self-reinforced ultra-high molecular weight polyethylene composites
US5549700A (en) * 1993-09-07 1996-08-27 Ortho Development Corporation Segmented prosthetic articulation
US5407623A (en) * 1994-01-06 1995-04-18 Polteco, Inc. Process for obtaining ultra-high modulus line products with enhanced mechanical properties
US5593719A (en) * 1994-03-29 1997-01-14 Southwest Research Institute Treatments to reduce frictional wear between components made of ultra-high molecular weight polyethylene and metal alloys
US5515590A (en) * 1994-07-19 1996-05-14 University Of Kentucky Research Foundation Method for reducing the generation of wear particulates from an implant
US6168626B1 (en) * 1994-09-21 2001-01-02 Bmg Incorporated Ultra high molecular weight polyethylene molded article for artificial joints and method of preparing the same
US6506866B2 (en) * 1994-11-17 2003-01-14 Dow Global Technologies Inc. Ethylene copolymer compositions
US6281264B1 (en) * 1995-01-20 2001-08-28 The Orthopaedic Hospital Chemically crosslinked ultrahigh molecular weight polyethylene for artificial human joints
US5869575A (en) * 1995-08-02 1999-02-09 The Dow Chemical Company Ethylene interpolymerizations
US6005053A (en) * 1996-01-22 1999-12-21 The Dow Chemical Company Polyolefin elastomer blends exhibiting improved properties
US6786933B2 (en) * 1996-02-13 2004-09-07 The General Hospital Corporation Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US6641617B1 (en) * 1996-02-13 2003-11-04 The General Hospital Corp. Radiation and melt treated ultra high molecular weight polyethylene prosthetic device and method
US5879400A (en) * 1996-02-13 1999-03-09 Massachusetts Institute Of Technology Melt-irradiated ultra high molecular weight polyethylene prosthetic devices
US6464926B1 (en) * 1996-02-13 2002-10-15 The General Hospital Corporation Process of making ultra high molecular weight polyethylene prosthetic devices
US5753182A (en) * 1996-02-14 1998-05-19 Biomet, Inc. Method for reducing the number of free radicals present in ultrahigh molecular weight polyethylene orthopedic components
US6228900B1 (en) * 1996-07-09 2001-05-08 The Orthopaedic Hospital And University Of Southern California Crosslinking of polyethylene for low wear using radiation and thermal treatments
US6017975A (en) * 1996-10-02 2000-01-25 Saum; Kenneth Ashley Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance
US6316158B1 (en) * 1996-10-02 2001-11-13 Depuy Orthopaedics, Inc. Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance
US6242507B1 (en) * 1996-10-02 2001-06-05 Depuy Orthopaedics, Inc. Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance
US6165220A (en) * 1996-10-15 2000-12-26 The Orthopaedic Hospital Wear resistant surface-gradient crosslinked polyethylene
US5874123A (en) * 1997-01-24 1999-02-23 Park; Joon B. Precoated polymeric prosthesis and process for making same
US6096084A (en) * 1998-09-04 2000-08-01 Biopro, Inc. Modular ball and socket joint preferably with a ceramic head ball
US6355215B1 (en) * 1999-03-10 2002-03-12 Implex Corp. Wear-resistant olefinic medical implant and thermal treatment container therefor
US6245276B1 (en) * 1999-06-08 2001-06-12 Depuy Orthopaedics, Inc. Method for molding a cross-linked preform
US6184265B1 (en) * 1999-07-29 2001-02-06 Depuy Orthopaedics, Inc. Low temperature pressure stabilization of implant component
US7517919B2 (en) * 2002-06-06 2009-04-14 Howmedica Osteonics Corp. Sequentially cross-linked polyethylene
US20050043431A1 (en) * 2002-06-06 2005-02-24 Howmedica Osteonics Corp. Sequentially cross-linked polyethylene
US20080215142A1 (en) * 2007-03-02 2008-09-04 The General Hospital Corporation Dba Massachusetts General Hospital Cross-linking of antioxidant-containing polymers
US20080319137A1 (en) * 2007-04-10 2008-12-25 Zimmer, Inc. Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8865788B2 (en) 1996-02-13 2014-10-21 The General Hospital Corporation Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US7858671B2 (en) 1996-02-13 2010-12-28 The General Hospital Corporation Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US8263676B2 (en) 1996-02-13 2012-09-11 The General Hospital Corporation Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US8563623B2 (en) 1996-02-13 2013-10-22 The General Hospital Corporation Radiation melt treated ultra high molecular weight polyethylene prosthetic devices
US8003709B2 (en) * 1996-07-09 2011-08-23 Orthopaedic Hospital Crosslinking of polyethylene for low wear using radiation and thermal treatments
US8008365B2 (en) * 1996-07-09 2011-08-30 Orthopaedic Hospital Crosslinking of polyethylene for low wear using radiation and thermal treatments
US7846376B2 (en) 2005-08-18 2010-12-07 Zimmer Gmbh Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles
US8673202B2 (en) 2005-08-18 2014-03-18 Zimmer, Gmbh Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles
US8470903B2 (en) 2005-08-18 2013-06-25 Zimmer Gmbh Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles
US7863348B2 (en) 2005-08-18 2011-01-04 Zimmer Gmbh Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles
US20090306781A1 (en) * 2006-02-06 2009-12-10 Masayuki Kyomoto High Wear-Resistant Bearing Material and Artificial Joint Replacement Using the Same
US9044323B2 (en) 2006-02-06 2015-06-02 Kyocera Medical Corporation High wear-resistant bearing material and artificial joint replacement using the same
US9822224B2 (en) 2007-04-10 2017-11-21 Zimmer, Inc. Antioxidant stabilized crosslinked ultra high molecular weight polyethylene for medical device applications
US8178594B2 (en) 2007-04-10 2012-05-15 Zimmer, Inc. Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
US9277949B2 (en) 2007-04-10 2016-03-08 Zimmer, Inc. Antioxidant stabilized crosslinked ultra high molecular weight polyethylene for medical device applications
US8129440B2 (en) 2007-04-10 2012-03-06 Zimmer, Inc. Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
US8669299B2 (en) 2007-04-10 2014-03-11 Zimmer, Inc. Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
US9926432B2 (en) 2007-04-10 2018-03-27 Zimmer, Inc. Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
US20100029858A1 (en) * 2007-04-10 2010-02-04 Zimmer, Inc. Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
US9265545B2 (en) 2007-04-10 2016-02-23 Zimmer, Inc. Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
US8664290B2 (en) 2007-04-10 2014-03-04 Zimmer, Inc. Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
US8652212B2 (en) 2008-01-30 2014-02-18 Zimmer, Inc. Orthopedic component of low stiffness
US9718241B2 (en) 2008-01-30 2017-08-01 Zimmer, Inc. Method of manufacturing an acetabular component
US9745462B2 (en) 2008-11-20 2017-08-29 Zimmer Gmbh Polyethylene materials
US9283079B2 (en) 2009-12-21 2016-03-15 Derek James Wallace McMinn Cup with crosslinked polymer layer cable ties
US9649193B2 (en) 2009-12-21 2017-05-16 Derek James Wallace McMinn Cup with crosslinked polymer layer modular pegs
US9017416B2 (en) 2009-12-21 2015-04-28 Derek J. McMinn Method of forming a polymer component
US20110153025A1 (en) * 2009-12-21 2011-06-23 Mcminn Derek J Method of Forming a Polymer Component
US9956081B2 (en) 2009-12-21 2018-05-01 Derek James Wallace McMinn Cup with cross-linked polymer layer
US8399535B2 (en) 2010-06-10 2013-03-19 Zimmer, Inc. Polymer [[s]] compositions including an antioxidant
US9708467B2 (en) 2013-10-01 2017-07-18 Zimmer, Inc. Polymer compositions comprising one or more protected antioxidants

Also Published As

Publication number Publication date Type
US20040132856A1 (en) 2004-07-08 application
US20050096749A1 (en) 2005-05-05 application
US20120060852A1 (en) 2012-03-15 application
US20030105182A1 (en) 2003-06-05 application
US20090105364A1 (en) 2009-04-23 application
US20050010288A1 (en) 2005-01-13 application
US20030013781A1 (en) 2003-01-16 application
US20120016051A1 (en) 2012-01-19 application
US20050006821A1 (en) 2005-01-13 application
US6786933B2 (en) 2004-09-07 grant
US7858671B2 (en) 2010-12-28 grant
US8865788B2 (en) 2014-10-21 grant
US8263676B2 (en) 2012-09-11 grant
US20010027345A1 (en) 2001-10-04 application
US20030119935A1 (en) 2003-06-26 application
US20050056971A1 (en) 2005-03-17 application
US20020007219A1 (en) 2002-01-17 application

Similar Documents

Publication Publication Date Title
US5645594A (en) Polymer composite implant and method of making the same
US6355215B1 (en) Wear-resistant olefinic medical implant and thermal treatment container therefor
US5037928A (en) Process of manufacturing ultrahigh molecular weight linear polyethylene shaped articles
Shen et al. Irradiation of chemically crosslinked ultrahigh molecular weight polyethylene
US20080140196A1 (en) Solid state deformation processing of crosslinked high molecular weight polymeric materials
US20030125513A1 (en) Orthopaedic device for implantation in the body of an animal and method for making the same
Blunn et al. Polyethylene wear in unicondylar knee prostheses: 106 retrieved Marmor. PCA. and St Georg tibial components compared
US6316158B1 (en) Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance
US7819925B2 (en) Composite prosthetic bearing having a crosslinked articulating surface and method for making the same
US20090192610A1 (en) Orthopedic component of low stiffness
US6395799B1 (en) Electromagnetic and mechanical wave energy treatments of UHMWPE
US7384430B2 (en) Low crystalline polymeric material for orthopaedic implants and an associated method
US20080215142A1 (en) Cross-linking of antioxidant-containing polymers
McKellop et al. Effect of molecular weight, calcium stearate, and sterilization methods on the wear of ultra high molecular weight polyethylene acetabular cups in a hip joint simulator
US20100082101A1 (en) Highly crystalline polyethylene
US5721334A (en) Process for producing ultra-high molecular weight low modulus polyethylene shaped articles via controlled pressure and temperature and compositions and articles produced therefrom
US20100190882A1 (en) Methods for making oxidation-resistant cross-linked polymeric materials
US6168626B1 (en) Ultra high molecular weight polyethylene molded article for artificial joints and method of preparing the same
US7304097B2 (en) High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
WO2004032987A1 (en) Medical device comprising a bio-compatible polymeric product with a layered structure
WO2001005337A1 (en) Polyethylene hip joint prosthesis with extended range of motion
US20050069696A1 (en) Medical implant or medical implant part and method for producing the same
Goldman et al. Comparison of the effects of gamma radiation and low temperature hydrogen peroxide gas plasma sterilization on the molecular structure, fatigue resistance, and wear behavior of UHMWPE
WO2005074619A2 (en) Highly crystalline cross-linked oxidation-resistant polyethylene
US6245276B1 (en) Method for molding a cross-linked preform